Processing 00000000.tx.1: -Synuclein Is Degraded by Both Autophagy and the Proteasome* Julie L. 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Is"

Phrase: "Degraded by Both Autophagy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0004391:Autophagy [Cell Function]
   770   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "and"

Phrase: "the Proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "* Julie L."
Processing 00000000.tx.2: Webb, Brinda Ravikumar, Jane Atkins, Jeremy N. 

Phrase: "Webb,"

Phrase: "Brinda Ravikumar,"

Phrase: "Jane Atkins,"

Phrase: "Jeremy N."
Processing 00000000.tx.3: Skepper and David C. 

Phrase: "Skepper"

Phrase: "and"

Phrase: "David C."
Processing 00000000.tx.4: Rubinsztein From the Department of Medical Genetics, Cambridge Institute for Medical Research, Wellcome/Medical Research Council Building, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2XY, United Kingdom and the Department of Anatomy, Cambridge University, Downing Street, Cambridge CB2 3DY, United Kingdom Received for publication, January 8, 2003 , and in revised form, April 15, 2003.  

Phrase: "Rubinsztein From the Department of Medical Genetics,"

Phrase: "Cambridge Institute for Medical Research,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0035172:Research Institute [Organization]
   760   C0021622:institute [Organization]
   760   C1272753:Institute [Idea or Concept]

Phrase: "Wellcome/Medical Research Council Building,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1547706:Building [Functional Concept]
   804   C1999269:Building [Manufactured Object]

Phrase: "Addenbrooke's Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "Hills Road,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442650:Road [Manufactured Object]

Phrase: "Cambridge CB2 2XY,"

Phrase: "United Kingdom"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041700:United Kingdom [Geographic Area]
   861   C1708611:Kingdom [Classification]
   827   C0166872:unite [Biomedical or Dental Material]

Phrase: "and"

Phrase: "the Department of Anatomy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "Cambridge University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Downing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205104:Down [Spatial Concept]

Phrase: "Street,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442658:Street [Manufactured Object]
  1000   C1301826:Street [Finding]

Phrase: "Cambridge CB2 3DY,"

Phrase: "United Kingdom"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041700:United Kingdom [Geographic Area]
   861   C1708611:Kingdom [Classification]
   827   C0166872:unite [Biomedical or Dental Material]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "January 8,"

Phrase: "2003 ,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "April 15,"

Phrase: "2003."
Processing 00000000.tx.5: ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Parkinson's disease (PD) is characterized by the loss of dopaminergic neurons in the substantia nigra and the formation of aggregates (Lewy bodies) in neurons. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "(PD)"

Phrase: "is"

Phrase: "characterized by the loss of dopaminergic neurons"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   853   C3550005:Loss of dopaminergic neurons [Finding]
   804   C0598940:Loss of neurons [Finding]
           neuron loss
   778   C1512035:Dopaminergic Neurons [Cell]
   748   C0027882:Neurons [Cell]
   748   C0282151:Dopaminergic [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   748   C1517945:Loss [Quantitative Concept]
   748   C1880022:Characterized [Activity]
   732 E C1850496:Neuronal loss [Finding]

Phrase: "in the substantia nigra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "the formation of aggregates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "(Lewy bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: ")"

Phrase: "in neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.6: -Synuclein is the major protein in Lewy bodies and rare mutations in -synuclein cause early-onset PD. 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "the major protein in Lewy bodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1325683:protein body [Cell Component]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "rare mutations in -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "early-onset PD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1833334:Early-onset [Finding]
Processing 00000000.tx.7: Consequently, -synuclein is implicated in the pathogenesis of PD. 

Phrase: "Consequently, -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "implicated in the pathogenesis of PD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0543483:pathogenesis [Functional Concept]
   753   C0699748:Pathogenesis [Pathologic Function]
Processing 00000000.tx.8: Here, we have investigated the degradation pathways of -synuclein, using a stable inducible PC12 cell model, where the expression of exogenous human wild-type, A30P, or A53T -synuclein can be switched on and off. 

Phrase: "Here,"

Phrase: "we"

Phrase: "have"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the degradation pathways of -synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a stable inducible PC12 cell model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3161035:Model [Intellectual Product]

Phrase: "where"

Phrase: "the expression of exogenous human wild-type, A30P,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "A53T -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "be"

Phrase: "switched"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707719:Switch [Manufactured Object]

Phrase: "on and off."
Processing 00000000.tx.9: We have used a panel of inhibitors/stimulators of autophagy and proteasome function and followed -synuclein degradation in these cells. 

Phrase: "We"

Phrase: "have"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a panel of inhibitors/stimulators of autophagy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0441833:Panel [Idea or Concept]
   748   C1999270:Panel [Intellectual Product]
   748   C3537156:Panel [Manufactured Object]

Phrase: "and"

Phrase: "proteasome function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "followed -"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332283:followed [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "synuclein degradation in these cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]
Processing 00000000.tx.10: We found that not only is -synuclein degraded by the proteasome, but it is also degraded by autophagy. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "not only is -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "degraded by the proteasome,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1325620:proteasome [Cell Component]
   770   C1752727:Proteasome [Molecular Function]
   770   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "but"

Phrase: "it"

Phrase: "is"

Phrase: "also"

Phrase: "degraded by autophagy."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0004391:Autophagy [Cell Function]
   790   C1881707:DEGRADED [Phenomenon or Process]
Processing 00000000.tx.11: A role for autophagy was further supported by the presence of -synuclein in organelles with the ultrastructural features of autophagic vesicles. 

Phrase: "A role for autophagy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "supported by the presence of -synuclein"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C1521721:Supported [Conceptual Entity]
   719 E C0183683:Support [Medical Device]

Phrase: "in organelles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029219:Organelles [Cell Component]

Phrase: "with the ultrastructural features"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   983   C1268455:Ultrastructural feature [Cell Component]
   827   C1521970:Feature [Qualitative Concept]
   827   C1706388:Feature [Conceptual Entity]
   827   C2346469:Feature [Qualitative Concept]
   827   C2348519:Feature [Qualitative Concept]

Phrase: "of autophagic vesicles."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]
Processing 00000000.tx.12: Since rapamycin, a stimulator of autophagy, increased clearance of -synuclein, it merits consideration as a potential therapeutic for Parkinsons disease, as it is designed for chronic use in humans.  

Phrase: "Since"

Phrase: "rapamycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072980:Rapamycin [Antibiotic,Organic Chemical]

Phrase: "a stimulator of autophagy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0175727:Stimulator [Medical Device]

Phrase: "increased clearance of -synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "it"

Phrase: "merits"

Phrase: "consideration as a potential therapeutic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0518609:consideration [Finding]

Phrase: "for Parkinsons disease,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   755   C1021144:Parkinsonia [Plant]

Phrase: "as"

Phrase: "it"

Phrase: "is"

Phrase: "designed for chronic use"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0042153:use [Functional Concept]
   770   C0205191:chronic [Temporal Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]
   737   C1707689:Design [Activity]
   737   C2983265:DESIGN [Intellectual Product]

Phrase: "in humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]
Processing 00000000.tx.13: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Parkinson's disease (PD)1 is caused by the degeneration of dopaminergic neurons in the substantia nigra. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "(PD)1"

Phrase: "is"

Phrase: "caused by the degeneration of dopaminergic neurons"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C1512035:Dopaminergic Neurons [Cell]
   774   C0027746:degeneration neurons [Cell or Molecular Dysfunction]
   748   C0011164:Degeneration [Pathologic Function]
   748   C0027882:Neurons [Cell]
   748   C0282151:Dopaminergic [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   748   C1880269:Degeneration [Functional Concept]
   714   C0015127:cause [Functional Concept]
   714   C1524003:Cause [Conceptual Entity]

Phrase: "in the substantia nigra."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]
Processing 00000000.tx.14: The pathogenic hallmark of PD is the accumulation and aggregation of -synuclein in susceptible neurons. 

Phrase: "The pathogenic hallmark of PD"

Phrase: "is"

Phrase: "the accumulation"

Phrase: "and"

Phrase: "aggregation of -synuclein in susceptible neurons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.15: The cytoplasmic aggregates/inclusions characteristic of PD are called Lewy bodies and their major constituent is -synuclein (1). 

Phrase: "The cytoplasmic aggregates/inclusions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0205708:Cytoplasmic Inclusions [Cell Component]
   793   C1512693:Inclusion [Qualitative Concept]
   717   C0544950:Cytoplasmic aggregate [Cell or Molecular Dysfunction]

Phrase: "characteristic of PD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1521970:Characteristic [Qualitative Concept]

Phrase: "are"

Phrase: "called"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0679006:Call [Mental Process]
   966   C1947967:Call [Functional Concept]

Phrase: "Lewy bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "and"

Phrase: "their major constituent is -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.16: Lewy pathology is also found in dementia with Lewy bodies, the Lewy body variant of Alzheimer's disease, in neurodegeneration with brain iron accumulation type I and in glial cytoplasmic inclusions of multiple system atrophy. 

Phrase: "Lewy pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "is"

Phrase: "also"

Phrase: "found in dementia"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0011265:dementia [Mental or Behavioral Dysfunction]
   790   C0150312:Found [Quantitative Concept]
   790   C0497327:Dementia [Mental or Behavioral Dysfunction]
   756 E C0243095:Find [Finding]

Phrase: "with Lewy bodies,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "the Lewy body variant of Alzheimer's disease,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205419:Variant [Qualitative Concept]

Phrase: "in neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "with brain iron accumulation type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "and in glial cytoplasmic inclusions of multiple system atrophy."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   790   C0037019:Multiple System Atrophy [Disease or Syndrome]
   790   C0393571:Multiple System Atrophy [Disease or Syndrome]
   773   C3548440:glial cytoplasmic inclusion [Cell Component]
   764   C0205708:Cytoplasmic Inclusions [Cell Component]
   742   C0010834:Cytoplasmic [Cell Component]
   742   C0027836:Glial [Cell]
   742   C0333641:Atrophy [Pathologic Function]
   742   C0439064:Multiple [Quantitative Concept]
   742   C0449913:System [Functional Concept]
   742   C0521449:Cytoplasmic [Body Location or Region]
   742   C1515981:And [Idea or Concept]
   742   C1553451:System [Manufactured Object]
   742   C1704459:System [Medical Device]
   708   C1512693:Inclusion [Qualitative Concept]
Processing 00000000.tx.17: These diseases are collectively known as "-synucleinopathies" (2, 3). 

Phrase: "These diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Diseases [Disease or Syndrome]
   928 E C1836721:MALS [Finding]
   928 E C3538764:MALS [Gene or Genome]
   928 E C3540595:MAL [Gene or Genome]

Phrase: "are"

Phrase: "collectively"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "as ""-synucleinopathies"""

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.18: -Synuclein is likely to play a role in PD, since two missense mutations in -synuclein (A53T and A30P) cause autosomal dominant, early-onset PD (4, 5), and animal models overexpressing -synuclein develop a disease phenotype with Lewy body-like pathology and locomotor impairment (6, 7). 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in PD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "since"

Phrase: "two missense mutations in -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A53T"

Phrase: "and"

Phrase: "A30P"

Phrase: ")"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "autosomal dominant, early-onset PD (4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0443147:Autosomal dominant [Intellectual Product]
   827   C1833334:Early-onset [Finding]
   799   C0332162:Onset [Qualitative Concept]
   799   C0596142:autosomal [Cell Component]
   799   C1279919:Early [Temporal Concept]
   799   C1527180:Dominant [Functional Concept]

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "animal models overexpressing -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "develop"

Phrase: "a disease phenotype with Lewy body-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031437:Phenotype [Organism Attribute]
   753   C1285572:Phenotype [Laboratory Procedure]

Phrase: "like pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]

Phrase: "and"

Phrase: "locomotor impairment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0684336:Impairment [Pathologic Function]

Phrase: "(6,"

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.19: However, while -synuclein knock-out mice show some disruption in synaptic neurotransmission, they do not manifest obvious disease and develop normally, with a normal life span and behavior (8, 9, 10). 

Phrase: "However,"

Phrase: "while -"

Phrase: "synuclein knock-out mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0206745:Knock-out Mice [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "some disruption in synaptic neurotransmission,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332453:Disruption [Functional Concept]

Phrase: "they"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "manifest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205319:Manifest [Functional Concept]

Phrase: "obvious disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "develop"

Phrase: "normally,"

Phrase: "with a normal life span"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0870809:life span [Group Attribute]
   827   C0376558:Life [Idea or Concept]
   827   C1711300:Span [Conceptual Entity]
   827   C2700613:Span [Quantitative Concept]
   743 E C0595998:lives [Finding]

Phrase: "and"

Phrase: "behavior"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0004927:Behavior [Individual Behavior]
  1000   C2707008:Behavior [Clinical Attribute]
   928 E C2986890:Behavioral [Idea or Concept]

Phrase: "(8,"

Phrase: "9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.20: Two other forms of inherited PD are caused by mutations in Parkin (an E3 ubiquitin ligase) (11) and ubiquitin carboxyL-terminal hydrolase L1 (UCH-L1) (12). 

Phrase: "Two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "other forms of inherited PD"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0348078:forms [Qualitative Concept]
   760   C0376315:Forms [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "are"

Phrase: "caused by mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0026882:Mutations [Genetic Function]
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "("

Phrase: "an E3 ubiquitin ligase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0077678:E3 Ubiquitin Ligase [Amino Acid, Peptide, or Protein,Enzyme]
           E3 Ligase
  1000   C1418270:E3 ubiquitin ligase [Gene or Genome]
   827   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "(11"

Phrase: ")"

Phrase: "and"

Phrase: "ubiquitin carboxyL-terminal hydrolase L1 (UCH-L1)"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   937   C0164005:Ubiquitin Carboxyl-Terminal Hydrolase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0020289:Hydrolase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0205088:Terminal [Temporal Concept]
   804   C0441918:L1 [Finding]
   804   C0596260:Carboxyl [Organic Chemical]
   804   C1179698:L1 [Body Location or Region]
   804   C1416177:L1 [Gene or Genome]
   804   C1705314:Terminal [Manufactured Object]
   804   C1705315:Terminal [Spatial Concept]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.21: Both of these proteins are involved in the ubiquitin-dependent degradation of intracellular proteins (13). 

Phrase: "Both of these proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0238767:Both [Spatial Concept]
   770   C1706086:Both [Qualitative Concept]

Phrase: "are"

Phrase: "involved in the ubiquitin-dependent degradation of intracellular proteins"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   796   C1157991:ubiquitin-dependent protein degradation [Molecular Function]
   745   C0597297:Protein Degradation [Molecular Function]
   745   C0597304:Protein Degradation [Molecular Function]
   745   C1623036:Protein Degradation [Molecular Function]
   742   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0175996:intracellular [Cell Component]
   742   C0178719:Intracellular [Spatial Concept]
   742   C0243125:degradation [Functional Concept]
   742   C0699900:Degradation [Organism Function]
   742   C0851827:Dependent [Qualitative Concept]
   742   C1314939:Involved [Functional Concept]
   742   C1701901:Dependent [Qualitative Concept]
   742   C3244310:dependent [Functional Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.22: This evidence and the identification of proteasome subunits in Lewy bodies (14) has led to the speculation that an impairment of the ubiquitin-proteasome system may contribute to the progression of PD. 

Phrase: "This evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "and"

Phrase: "the identification of proteasome subunits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "in Lewy bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "(14"

Phrase: ")"

Phrase: "has"

Phrase: "led to the speculation"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   770   C1708698:LED [Manufactured Object]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C1522538:Lead [Functional Concept]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "an impairment of the ubiquitin-proteasome system"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0684336:Impairment [Pathologic Function]

Phrase: "may"

Phrase: "contribute to the progression of PD."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0242656:progression [Pathologic Function]
   753   C0449258:Progression [Functional Concept]
   753   C1880177:Contribute [Activity]
Processing 00000000.tx.23: A number of studies have investigated the effect of proteasomal inhibition on -synuclein metabolism, with conflicting results. 

Phrase: "A number of studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "have"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the effect of proteasomal inhibition on -synuclein metabolism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "with conflicting results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.24: Some groups reported that proteasomal inhibition caused an accumulation of -synuclein, inclusion formation and increased cell death (15, 16, 17), while other studies suggested -synuclein is not a proteasome substrate (18, 19). 

Phrase: "Some groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that proteasomal inhibition"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   964   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "an accumulation of -synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "inclusion formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "increased cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "(15,"

Phrase: "16,"

Phrase: "17"

Phrase: ")"

Phrase: ","

Phrase: "while"

Phrase: "other studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "suggested -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a proteasome substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710236:Substrate [Manufactured Object]

Phrase: "(18,"

Phrase: "19"

Phrase: ")."
Processing 00000000.tx.25: Another pathway that may be relevant to -synuclein clearance is autophagy, a process mediating bulk degradation of cytoplasmic proteins or organelles in the lytic compartment. 

Phrase: "Another pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathway [Molecular Function]
  1000   C1705987:Pathway [Conceptual Entity]

Phrase: "that"

Phrase: "may"

Phrase: "be"

Phrase: "relevant to -synuclein clearance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0449297:Clearance [Qualitative Concept]
   812   C1382187:Clearance [Clinical Attribute]
   812   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "autophagy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004391:Autophagy [Cell Function]

Phrase: "a process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "bulk degradation of cytoplasmic proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   781   C0597297:Protein Degradation [Molecular Function]
   781   C0597304:Protein Degradation [Molecular Function]
   781   C1623036:Protein Degradation [Molecular Function]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "or"

Phrase: "organelles in the lytic compartment."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0029219:Organelles [Cell Component]
Processing 00000000.tx.26: Autophagy involves the formation of double-membrane structures called autophagosomes, which fuse with primary lysosomes to become an autophagolysosome where their content is degraded and then either disposed of or recycled back to the cell (20). 

Phrase: "Autophagy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004391:Autophagy [Cell Function]

Phrase: "involves"

Phrase: "the formation of double-membrane structures called autophagosomes,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   750   C2611772:autophagosome formation [Cell Function]
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C1522492:Formation [Functional Concept]

Phrase: "which"

Phrase: "fuse with primary lysosomes to"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   773   C0230814:Primary lysosome [Cell Component]
   760   C0024369:Lysosomes [Cell Component]
   760   C0205225:Primary [Qualitative Concept]
   760   C0439631:Primary [Therapeutic or Preventive Procedure]
   760   C0699952:fuse [Functional Concept]
   760   C1414861:FUSE [Gene or Genome]
   760   C1708111:Fuse [Manufactured Object]
   726 E C2984253:Lysosome [Functional Concept]

Phrase: "become"

Phrase: "an autophagolysosome where"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230822:Autophagolysosome [Cell Component]

Phrase: "their content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0423896:Content [Mental Process]
  1000   C0456205:Content [Conceptual Entity]

Phrase: "is"

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "and"

Phrase: "then either"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883708:Then [Temporal Concept]

Phrase: "disposed of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1707797:Dispose [Activity]

Phrase: "or"

Phrase: "recycled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282114:recycled [Human-caused Phenomenon or Process]

Phrase: "back to the cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004600:Back [Body Location or Region]
   770   C0205095:Back [Spatial Concept]
   770   C0460009:Back [Body Location or Region]
   770   C1995000:Back [Body Location or Region]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.27: We have recently shown that aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy (21). 

Phrase: "We"

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that aggregate-prone proteins with polyglutamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "polyalanine expansions"

Phrase: "are"

Phrase: "degraded by autophagy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0004391:Autophagy [Cell Function]
   790   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.28: Since -synuclein is also an aggregate-prone protein, we have tested whether it is degraded by this pathway. 

Phrase: "Since -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "also"

Phrase: "an aggregate-prone protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "we"

Phrase: "have"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "whether"

Phrase: "it"

Phrase: "is"

Phrase: "degraded by this pathway."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1704259:Pathway [Molecular Function]
   770   C1705987:Pathway [Conceptual Entity]
   770   C1881707:DEGRADED [Phenomenon or Process]
Processing 00000000.tx.29: Our previous data suggested that aggregate-prone proteins were more likely to be cleared by autophagy than the more soluble species that did not have expanded polyglutamines or polyalanines. 

Phrase: "Our previous data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that aggregate-prone proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "more likely to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205172:More [Functional Concept]
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "cleared by autophagy"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0521097:Cleared by [Functional Concept]
           cleared
   790   C0004391:Autophagy [Cell Function]
   756 E C2963144:Clear [Qualitative Concept]

Phrase: "than the more soluble species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705920:Species [Conceptual Entity]

Phrase: "that"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "expanded polyglutamines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0384782:polyglutamine [Amino Acid, Peptide, or Protein]

Phrase: "or"

Phrase: "polyalanines."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0071505:polyalanine [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.30: In the context of -synuclein, this model predicts that the A53T mutation that forms aggregates most readily may be more dependent on autophagy than the wild-type protein or A30P mutation (that forms oligomers efficiently but not aggregates) (22). 

Phrase: "In the context of -synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "this model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "predicts"

Phrase: "that"

Phrase: "the A53T mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0348078:forms [Qualitative Concept]
  1000   C0376315:Forms [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: "most readily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205393:Most [Quantitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "more dependent on autophagy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0851827:Dependent [Qualitative Concept]
   770   C1701901:Dependent [Qualitative Concept]
   770   C3244310:dependent [Functional Concept]

Phrase: "than the wild-type protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "or"

Phrase: "A30P mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "("

Phrase: "that"

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "oligomers efficiently"

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: ")"

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.31: In this study, we have used PC12 cells to establish stable, doxycycline-inducible lines as they are dopaminergic and can be differentiated into a neuron-like phenotype with nerve growth factor (23). 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "have"

Phrase: "used PC12 cells to"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0085262:PC12 Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "stable, doxycycline-inducible lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0205132:lines [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "as"

Phrase: "they"

Phrase: "are"

Phrase: "dopaminergic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282151:Dopaminergic [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "can"

Phrase: "be"

Phrase: "differentiated into a neuron-like phenotype"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0007589:Differentiated [Cell Function]
   753   C0027882:Neuron [Cell]
   753   C0031437:Phenotype [Organism Attribute]
   753   C0205615:Differentiated [Qualitative Concept]
   753   C1285572:Phenotype [Laboratory Procedure]

Phrase: "with nerve growth factor"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
  1000   C0027752:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0027754:Nerve growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522443:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   873   C0814002:Neural Growth [Cell Function,Organism Function]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0027740:Nerve [Tissue]
   827   C0027757:NERVE [Tissue]
   827   C0220844:growth [Physiologic Function]
   827   C1280541:Nerve [Body Part, Organ, or Organ Component]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]
   771 E C0599851:Neural [Functional Concept]
   755 E C0027769:nervy [Sign or Symptom]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.32: We used the Tet-On system, where regulation of expression is achieved through a tetracycline-controlled transactivator. 

Phrase: "We"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Tet-On system,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515333:Tet [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "where regulation of expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "is"

Phrase: "achieved through a tetracycline-controlled transactivator."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   773   C1515335:Tetracycline Control [Molecular Biology Research Technique]
   753   C0039644:Tetracycline [Antibiotic,Organic Chemical]
   753   C0039651:tetracycline [Organic Chemical]
   753   C0040627:Trans-Activator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1744619:tetracycline [Antibiotic,Organic Chemical]
   753   C2587213:Controlled [Functional Concept]
   719 E C0243148:control [Qualitative Concept]
   719 E C1550141:Control [Substance]
   719 E C1882979:Control [Conceptual Entity]
   719 E C3274648:Control [Qualitative Concept]
Processing 00000000.tx.33: This allows us to turn on and off -synuclein expression by adding and then removing doxycycline and therefore enables us to follow -synuclein clearance. 

Phrase: "This"

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "us to turn on"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0541749:turn [Finding]
   827   C1709743:Turn [Spatial Concept]

Phrase: "and off -synuclein expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C1515981:And [Idea or Concept]

Phrase: "by adding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "removing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0849355:remove [Qualitative Concept]
   966   C1883720:Remove [Activity]
   966   C3244314:remove [Functional Concept]

Phrase: "doxycycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   944 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "therefore"

Phrase: "enables"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562342:enable [Mental Process]
  1000   C1171285:enable [Mental Process]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "follow -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: "synuclein clearance."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0449297:Clearance [Qualitative Concept]
   861   C1382187:Clearance [Clinical Attribute]
   861   C2825073:Clearance [Natural Phenomenon or Process]
Processing 00000000.tx.34: In our cell lines we found that -synuclein was degraded by both proteasome and autophagy pathways.  

Phrase: "In our cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "degraded by both proteasome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1325620:proteasome [Cell Component]
   770   C1752727:Proteasome [Molecular Function]
   770   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "and"

Phrase: "autophagy pathways."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.35: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Establishment of Inducible PC12 Cell LinesHuman -synuclein with a HA tag at the NH2 terminus and a His6 tag at the COOH terminus was amplified from pHM6-synuclein constructs (24) and inserted into pTRE2hyg vector (Clontech) using NheI/SalI sites. 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Establishment of Inducible PC12 Cell LinesHuman -synuclein"

Phrase: "with a HA tag"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037293:Tag [Neoplastic Process]
   861   C0181496:Tag [Manufactured Object]
   861   C1710492:TAG [Gene or Genome]

Phrase: "at the NH2 terminus"

Phrase: "and"

Phrase: "a His6 tag at the COOH terminus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1505208:his6 tag [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   748   C0037293:Tag [Neoplastic Process]
   748   C0181496:Tag [Manufactured Object]
   748   C1710492:TAG [Gene or Genome]

Phrase: "was"

Phrase: "amplified from pHM6-synuclein constructs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   726   C2827421:Construct [Classification]

Phrase: "(24"

Phrase: ")"

Phrase: "and"

Phrase: "inserted into pTRE2hyg vector"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0441587:Inserted [Health Care Activity]
   770   C0442335:Vector [Spatial Concept]
   770   C1705099:Vector [Idea or Concept]
   737 E C1743766:Insert [Medical Device]
   737 E C1883719:Insert [Functional Concept]

Phrase: "(Clontech"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "NheI/SalI sites."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.36: Constructs were confirmed by sequencing before use. 

Phrase: "Constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "were"

Phrase: "confirmed by sequencing"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0750484:Confirmed [Idea or Concept]
   790   C1553778:Sequencing [Intellectual Product]
   790   C1561491:Sequencing [Functional Concept]
   756 E C1456348:Confirm [Qualitative Concept]

Phrase: "before use."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]
Processing 00000000.tx.37: The pTRE2hyg-synuclein construct and pTet-tTS (Clontech) were co-transfected into PC12 Tet-On cells (Clontech), using LipofectAMINE (Invitrogen) and Plus Reagent (Invitrogen). 

Phrase: "The pTRE2hyg-synuclein construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "pTet-tTS (Clontech"

Phrase: ")"

Phrase: "were"

Phrase: "co-transfected into PC12 Tet-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0085262:PC-12 [Cell]
   760   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   760   C1515333:Tet [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "On cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "(Clontech"

Phrase: ")"

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "LipofectAMINE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0253711:Lipofectamine [Indicator, Reagent, or Diagnostic Aid,Lipid]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "and Plus Reagent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   790   C0332287:Plus [Qualitative Concept]
   790   C1515981:And [Idea or Concept]

Phrase: "(Invitrogen"

Phrase: ")."
Processing 00000000.tx.38: Single colonies were isolated using cloning cylinders (Sigma), and cells were grown and tested for -synuclein expression upon induction. 

Phrase: "Single colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439158:colonies [Quantitative Concept]
   827 E C1947989:Colony [Cell]

Phrase: "were"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "cloning cylinders"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0946010:cylinders [Spatial Concept]
   827 E C0181797:Cylinder [Medical Device]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown"

Phrase: "and"

Phrase: "tested for -synuclein expression"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C0392366:tested [Intellectual Product]
   737 E C0022885:Test [Laboratory Procedure]
   737 E C0039593:Test [Functional Concept]

Phrase: "upon induction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.39: Cell lines were subjected to a further round of purification from single colonies to ensure that lines were pure. 

Phrase: "Cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "subjected to a further round of purification"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   748   C0243114:purification [Functional Concept]
   748   C0332490:Round [Spatial Concept]
   748   C1517331:Further [Spatial Concept]
   748   C1998793:Purification [Functional Concept]
   714 E C0205108:far [Spatial Concept]
   714   C0681850:Subject [Group]
   714   C1550501:{Subject} [Idea or Concept]
   714   C1706203:Subject [Idea or Concept]
   714   C2349001:Subject [Human]
   714   C2697811:Subject [Functional Concept]

Phrase: "from single colonies to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439158:colonies [Quantitative Concept]
   793 E C1947989:Colony [Cell]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "that lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205132:lines [Spatial Concept]
   966 E C1550648:Line [Substance]
   966 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "pure."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2247561:PurE [Molecular Function]
   928 E C1882508:Purity [Quantitative Concept]
Processing 00000000.tx.40: Cell CulturePC12 cells were grown in Dulbecco's modified Eagle's medium (Sigma) supplemented with 10% horse serum (Sigma), 5% fetal bovine serum (Sigma), 100 units/ml penicillin/streptomycin, 2 mM L-glutamine, 50 g/ml G418 (Invitrogen), and 149 g/ml hygromycin B (Calbiochem) at 37 C, 10%CO2. 

Phrase: "Cell CulturePC12 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]

Phrase: "were"

Phrase: "grown in Dulbecco's modified Eagle's medium"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0009458:Medium [Intellectual Product]
   753   C0325564:Eagle [Bird]
   753   C0392747:Modified [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C1551720:Eagle [Population Group]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "supplemented with 10% horse serum"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C1518416:Serum, Horse [Immunologic Factor]
   760   C0019944:Horse [Mammal]
   760   C0229671:Serum [Body Substance]
   760   C0242616:Horse [Mammal]
   760   C1265527:Horse [Mammal]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   726   C0242295:Supplement [Food]
   726   C1947943:Supplement [Intellectual Product]
   726   C2348609:Supplement [Functional Concept]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "5% fetal bovine serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0007452:Bovine [Mammal]
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0521457:Fetal [Functional Concept]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "100 units/ml penicillin/streptomycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "2 mM L-glutamine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "50 g/ml G418"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0052009:G418 [Antibiotic,Organic Chemical]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "149 g/ml hygromycin B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0020406:Hygromycin B [Carbohydrate,Pharmacologic Substance]
   804   C0063201:hygromycin [Organic Chemical]

Phrase: "(Calbiochem"

Phrase: ")"

Phrase: "at 37 C,"

Phrase: "10%CO2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347816:Co2+ [Element, Ion, or Isotope]
Processing 00000000.tx.41: To induce differentiation, cells were grown in media containing 1% horse serum and 100 ng/ml nerve growth factor (2.5 S, Upstate Biotechnology) and incubated for about 5 days. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "differentiation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown in media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0009458:Media [Intellectual Product]
   790   C0162867:Media [Tissue]
   790   C1254021:Media [Tissue]
   756 E C0439536:Medium [Quantitative Concept]
   756 E C1705217:Medium [Substance]
   756 E C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% horse serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C1518416:Serum, Horse [Immunologic Factor]
   827   C0019944:Horse [Mammal]
   827   C0229671:Serum [Body Substance]
   827   C0242616:Horse [Mammal]
   827   C1265527:Horse [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "100 ng/ml nerve growth factor"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   861   C0027752:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0027754:Nerve growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1522443:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0027740:Nerve [Tissue]
   799   C0027757:NERVE [Tissue]
   799   C0220844:growth [Physiologic Function]
   799   C0814002:Neural Growth [Cell Function,Organism Function]
   799   C1280541:Nerve [Body Part, Organ, or Organ Component]
   799   C1521761:Factor [Functional Concept]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0599851:Neural [Functional Concept]
   727 E C0027769:nervy [Sign or Symptom]

Phrase: "(2.5 S,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0450346:2 5 [Quantitative Concept]

Phrase: "Upstate Biotechnology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: ")"

Phrase: "and"

Phrase: "incubated for about 5 days."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0439228:days [Temporal Concept]
   760   C1439852:Incubated [Laboratory Procedure]
   726 E C0332173:/day [Temporal Concept]
   726 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.42: Cells were induced to express synuclein with 2 g/ml doxycycline (Sigma). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "synuclein with 2 g/ml doxycycline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.43: ImmunofluorescenceCoverslips were placed in six-well dishes and coated with 0.01% poly-L-lysine (Sigma). 

Phrase: "ImmunofluorescenceCoverslips"

Phrase: "were"

Phrase: "placed in six-well"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0205170:Well [Qualitative Concept]
   770   C0205452:Six [Quantitative Concept]
   770   C3146287:Well [Manufactured Object]
   737   C0442504:Place [Spatial Concept]
   737   C1704765:Place [Functional Concept]
   737   C1882509:Place [Activity]
   737   C3496241:place [Disease or Syndrome]

Phrase: "dishes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020498:DISH [Disease or Syndrome]

Phrase: "and"

Phrase: "coated with 0.01% poly-L-lysine"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   748   C0024337:Lysine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0747726:POLY [Conceptual Entity]
   748   C1522408:Coated [Qualitative Concept]
   714 E C0453946:Coat [Manufactured Object]
   714 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.44: Cells were seeded and induced with 2 g/ml doxycycline and incubated as necessary. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seeded"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0036563:Seed [Plant]
   966   C1705192:Seed [Laboratory Procedure]
   966   C1882540:{Seed} [Quantitative Concept]
   966   C2346495:Seed [Conceptual Entity]

Phrase: "and"

Phrase: "induced with 2 g/ml doxycycline"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C1300565:g/mL [Quantitative Concept]
   783 E C1637390:mL/g [Quantitative Concept]
   753   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   753   C0205263:Induced [Functional Concept]
   753   C0439267:g% [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "incubated as necessary."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]
Processing 00000000.tx.45: Cells were fixed with 4% paraformaldehyde (Sigma) for 30 min and then washed with PBS and permeabilized with 0.1% Triton-X-100 (Sigma) for 15 min. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "fixed with 4% paraformaldehyde"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "washed with PBS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1548982:Washed [Idea or Concept]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "permeabilized with 0.1% Triton-X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   814   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   778   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   748   C0242759:Triton [Geographic Area]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "for 15 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.46: Cells were blocked in 10% fetal calf serum for at least 30 min. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "blocked in 10% fetal calf serum"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   753   C0015965:Fetal [Embryonic Structure]
   753   C0028778:Blocked [Pathologic Function]
   753   C0229671:Serum [Body Substance]
   753   C0230445:Calf [Body Location or Region]
   753   C0332206:Blocked [Functional Concept]
   753   C0521457:Fetal [Functional Concept]
   753   C1305418:Calf [Body Part, Organ, or Organ Component]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   753   C2983591:BLOCKED [Research Activity]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "for"

Phrase: "at least 30 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0456693:/30 min [Temporal Concept]
   901   C1442458:30 min [Temporal Concept]
   827   C0702093:/min [Temporal Concept]
Processing 00000000.tx.47: Anti--synuclein monoclonal antibody (BD Biosciences) was used at 1:200 for 216 h, cells were washed and 1:200 Cy3-conjugated anti-mouse antibody (Jackson ImmunoResearch Laboratories) was added for 1 h. 

Phrase: "Anti"

Phrase: "--"

Phrase: "synuclein monoclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0746619:monoclonal [Finding]

Phrase: "(BD Biosciences"

Phrase: ")"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "at 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: ":"

Phrase: "200 for 216 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200 Cy3-conjugated anti-mouse antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   839   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Jackson ImmunoResearch Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022877:Laboratories [Manufactured Object,Organization]
   827   C1619828:Laboratories [Intellectual Product]
   793 E C3244292:laboratory [Functional Concept]

Phrase: ")"

Phrase: "was"

Phrase: "added for 1 h."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   819   C0700308:h 1 [Element, Ion, or Isotope]
   802   C0945818:Add 1 [Quantitative Concept]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1524062:Added [Functional Concept]
   737 E C1883712:Add [Functional Concept]
Processing 00000000.tx.48: This anti--synuclein antibody could detect both human and rat -synuclein; 

Phrase: "This anti"

Phrase: "--"

Phrase: "synuclein antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "could"

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "both human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "and"

Phrase: "rat -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.49: therefore, uninduced controls were performed in parallel to compare endogenous -synuclein levels. 

Phrase: "therefore,"

Phrase: "uninduced controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "in parallel to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0150312:In [Quantitative Concept]
   827   C0332285:In [Spatial Concept]
   827   C2348042:Parallel [Qualitative Concept]
   827   C2826345:PARALLEL [Research Activity]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "endogenous -synuclein levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.50: Staining was always considerably fainter in the uninduced controls. 

Phrase: "Staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "always considerably fainter in the uninduced controls."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0039070:Faint [Sign or Symptom]
Processing 00000000.tx.51: For double staining with LysoTracker Red (Molecular Probes) cells were incubated in Earle's balanced salts solution (Sigma) with 75 nM LysoTracker for 2 h at 37 C. 

Phrase: "For double staining"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0205173:Double [Functional Concept]
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]
   861   C1705764:Double [Activity]
   861   C1705765:Double [Qualitative Concept]
   827 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "with LysoTracker Red"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332575:Red [Finding]
   861   C1260956:Red [Qualitative Concept]
   861   C1531412:LysoTracker [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(Molecular Probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: ")"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated in Earle's balanced salts solution"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   822   C0543134:Balanced salt solution [Inorganic Chemical,Pharmacologic Substance]
   753   C0036140:Salts [Chemical Viewed Structurally]
   753   C0037633:Solution [Substance]
   753   C0205415:Balanced [Functional Concept]
   753   C0525069:Solution [Biomedical or Dental Material]
   753   C1439852:Incubated [Laboratory Procedure]
   719 E C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   719 E C0206136:Salt [Food,Inorganic Chemical]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "with 75 nM LysoTracker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1531412:LysoTracker [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "for 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 37 C."
Processing 00000000.tx.52: Cells were fixed and stained with anti--synuclein antibody and 1:200 fluorescein isothiocyanate-conjugated anti-mouse antibody (Jackson ImmunoResearch Laboratories) was used as secondary antibody. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "fixed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231441:Fixed [Finding]
  1000   C0443218:Fixed [Qualitative Concept]
  1000   C2827483:Fixed [Body Substance]

Phrase: "and"

Phrase: "stained with anti"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "--"

Phrase: "synuclein antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200 fluorescein isothiocyanate-conjugated anti-mouse antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   829   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   795   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Jackson ImmunoResearch Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022877:Laboratories [Manufactured Object,Organization]
   827   C1619828:Laboratories [Intellectual Product]
   793 E C3244292:laboratory [Functional Concept]

Phrase: ")"

Phrase: "was"

Phrase: "used as secondary antibody."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0027627:secondary [Neoplastic Process]
   770   C0175668:Secondary [Temporal Concept]
   770   C0205436:Secondary [Quantitative Concept]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.53: Slides were mounted in Citifluor (Citifluor Ltd.) with 3 g/ml 4',6-diamidino-2-phenylindole (DAPI, Sigma). 

Phrase: "Slides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0444330:slides [Research Device]
   966 E C1705201:Slide [Manufactured Object]

Phrase: "were"

Phrase: "mounted in Citifluor"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0449878:mounted [Finding]
   756 E C0181909:Mount [Medical Device]

Phrase: "(Citifluor Ltd.) with 3 g/ml 4',"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1136140:LTD [Organ or Tissue Function]

Phrase: "6-diamidino-2-phenylindole"

Phrase: "(DAPI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0057142:DAPI [Organic Chemical,Pharmacologic Substance]

Phrase: "Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.54: Cells were visualized using a Zeiss LSM510 confocal microscope. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "visualized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234621:Visualized [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Zeiss LSM510 confocal microscope."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1626420:Confocal microscope [Medical Device]
   812   C0181839:Microscope [Medical Device]
   812   C1706379:Microscope [Medical Device]
Processing 00000000.tx.55: Treatment with Autophagy/Proteasome DrugsCells were induced for 24 h and then washed twice with medium to remove doxycycline. 

Phrase: "Treatment with Autophagy/Proteasome DrugsCells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "were"

Phrase: "induced for 24 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0205263:Induced [Functional Concept]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with medium to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0009458:Medium [Intellectual Product]
   770   C0439536:Medium [Quantitative Concept]
   770   C1705217:Medium [Substance]
   770   C1720725:Twice [Intellectual Product]
   770   C1948050:Twice [Quantitative Concept]
   770   C3244283:medium [Intellectual Product]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "doxycycline."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   944 E C0699957:Vibramycin [Antibiotic,Organic Chemical]
Processing 00000000.tx.56: Then cells were incubated in media containing either 10 mM 3-methyladenine (3-MA, Sigma), 200 nM bafilomycin A1 (Sigma), 0.2 mg/ml rapamycin (Sigma), 10 M lactacystin (Sigma), 10 M epoxomicin (Affinity Research Products Ltd.) or carrier controls (water or Me2SO (Sigma)). 

Phrase: "Then cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated in media"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0009458:Media [Intellectual Product]
   790   C0162867:Media [Tissue]
   790   C1254021:Media [Tissue]
   790   C1439852:Incubated [Laboratory Procedure]
   756 E C0439536:Medium [Quantitative Concept]
   756 E C1705217:Medium [Substance]
   756 E C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "either 10 mM 3-methyladenine"

Phrase: "(3-MA,"

Phrase: "Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "200 nM bafilomycin A1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0052919:bafilomycin A1 [Organic Chemical,Pharmacologic Substance]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "0.2 mg/ml rapamycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0072980:Rapamycin [Antibiotic,Organic Chemical]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "10 M lactacystin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0125179:lactacystin [Antibiotic,Organic Chemical]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "10 M epoxomicin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0656383:epoxomicin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(Affinity Research Products Ltd.)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1136140:LTD [Organ or Tissue Function]

Phrase: "or"

Phrase: "carrier controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "(water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]

Phrase: "or"

Phrase: "Me2SO"

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ")."
Processing 00000000.tx.57: 3-MA and lactacystin were made up in water and rapamycin, epoxomicin, and bafilomycin were dissolved in Me2SO. 

Phrase: "3-MA"

Phrase: "and"

Phrase: "lactacystin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0125179:lactacystin [Antibiotic,Organic Chemical]

Phrase: "were"

Phrase: "made up in water"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1881534:Make [Functional Concept]

Phrase: "and"

Phrase: "rapamycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072980:Rapamycin [Antibiotic,Organic Chemical]

Phrase: "epoxomicin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0656383:epoxomicin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "bafilomycin"

Phrase: "were"

Phrase: "dissolved in Me2SO."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1549535:Dissolve [Functional Concept]
Processing 00000000.tx.58: After 24 h the medium was replaced with fresh medium plus drug, and after a further 24 h cell pellets were collected and stored at 80 C until required. 

Phrase: "After 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "replaced with fresh medium plus drug,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   753   C0009458:Medium [Intellectual Product]
   753   C0013227:Drug [Pharmacologic Substance]
   753   C0332287:Plus [Qualitative Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C0443224:Fresh [Qualitative Concept]
   753   C0559956:Replaced [Functional Concept]
   753   C1254351:Drug [Pharmacologic Substance]
   753   C1299987:replaced [Functional Concept]
   753   C1705217:Medium [Substance]
   753   C2827486:Fresh [Body Substance]
   753   C3244283:medium [Intellectual Product]
   719 E C1554078:Replace [Idea or Concept]

Phrase: "and after a further 24 h cell pellets"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   744   C0007634:Cell [Cell]
   744   C0033727:H+ [Element, Ion, or Isotope]
   744   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441932:H+ [Classification]
   744   C0564385:/h [Quantitative Concept]
   744   C0993610:pellets [Biomedical or Dental Material]
   744   C1269647:Cell [Cell]
   744   C1515981:And [Idea or Concept]
   744   C1517331:Further [Spatial Concept]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   711 E C0205108:far [Spatial Concept]
   711 E C0441436:Pellet [Manufactured Object]
   711 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "stored at 80 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1698986:Store [Functional Concept]

Phrase: "until"

Phrase: "required."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]
Processing 00000000.tx.59: Western Blot AnalysisCell pellets were collected and stored at 80 C until needed. 

Phrase: "Western Blot AnalysisCell pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0993610:pellets [Biomedical or Dental Material]
   779 E C0441436:Pellet [Manufactured Object]
   779 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "stored at 80 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1698986:Store [Functional Concept]

Phrase: "until"

Phrase: "needed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]
Processing 00000000.tx.60: Cells were lysed on ice in lysis buffer: 1% Triton-X-100, 20 mM Tris, pH 7.5, 137 mM NaCl, 1 mM EGTA, 10% glycerol, 1.5 mM MgCl2, and protease inhibitor mixture (Complete, Roche Applied Science). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed on ice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020746:Ice [Inorganic Chemical]
   790   C0024348:lysed [Pathologic Function]

Phrase: "in lysis buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: ":"

Phrase: "1% Triton-X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "20 mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "137 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "1 mM EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "10% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "1.5 mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "protease inhibitor mixture"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439962:Mixture [Substance]
   734   C0033607:Protease Inhibitor [Biologically Active Substance,Pharmacologic Substance]
   734   C3536890:Protease Inhibitor [Pharmacologic Substance]

Phrase: "(Complete, Roche Applied Science"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0681834:Applied Science [Research Activity]
   812   C0036397:Science [Occupation or Discipline]
   812   C0185125:Applied [Health Care Activity]
   779 E C1632850:Apply [Functional Concept]
   779 E C1879355:Apply [Functional Concept]

Phrase: ")."
Processing 00000000.tx.61: Samples were then mixed with loading buffer: 62.5 mM Tris, pH 6.8, 2% SDS, 10% glycerol, 0.05% bromphenol blue, 100 mM dithiothreitol, and 700 mM -mercaptoethanol and boiled before loading onto 14% denaturing polyacrylamide gels. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "mixed with loading buffer"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0205430:Mixed [Functional Concept]
   770   C1708715:Loading [Activity]
   770   C3160715:Mixed [Finding]
   737 E C1421951:MIX [Gene or Genome]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]
   737 E C1720722:Mix [Qualitative Concept]

Phrase: ":"

Phrase: "62.5 mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   812   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   812   C0814229:TRI [Intellectual Product]

Phrase: "pH 6.8,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "2% SDS,"

Phrase: "10% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "0.05% bromphenol blue,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006247:Bromphenol Blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C1260957:Blue [Qualitative Concept]

Phrase: "100 mM dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "700 mM -mercaptoethanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: "and"

Phrase: "boiled before loading"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1708715:Loading [Activity]
   756   C0242301:Boil [Disease or Syndrome]
   756   C1546559:Boil [Intellectual Product]

Phrase: "onto 14% denaturing polyacrylamide gels."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   812   C0017243:Gels [Biomedical or Dental Material]
   812   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   779 E C1382104:Gel [Substance]
Processing 00000000.tx.62: Each lane was loaded with protein from a similar number of cells, based on cell counting at the time of seeding. 

Phrase: "Each lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: "was"

Phrase: "loaded with protein"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1708715:Loaded [Activity]
   756 E C1550025:Load [Idea or Concept]
   756 E C1704782:Load [Manufactured Object]

Phrase: "from a similar number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "of cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "based on cell counting"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   833   C0007584:cell counting [Laboratory Procedure]
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1527178:Based [Functional Concept]
   770   C1704653:Cell [Medical Device]
   770   C1705938:Based [Idea or Concept]
   770   C1948049:Cell [Spatial Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737   C0750480:Count [Activity]
   737   C1705566:Count [Quantitative Concept]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "at the time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "of seeding."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705192:Seeding [Laboratory Procedure]
Processing 00000000.tx.63: Proteins were transferred onto Hybond ECL nitrocellulose membrane (Amersham Biosciences). 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "transferred onto Hybond ECL nitrocellulose membrane"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0025255:Membrane [Tissue]
   753   C0348011:transferred [Functional Concept]
   753   C0596901:Membrane [Cell Component]
   753   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   753   C1332684:ECL [Gene or Genome]
   753   C1706182:Membrane [Manufactured Object]
   719 E C0040671:Transfer [Mental Process]
   719 E C1705822:Transfer [Activity]

Phrase: "(Amersham Biosciences"

Phrase: ")."
Processing 00000000.tx.64: -Synuclein was detected with an anti-HA monoclonal antibody (Covance) at 1:1000 dilution with 418 h incubation. 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "detected with an anti-HA monoclonal antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0442726:Detected [Finding]
   748   C0746619:monoclonal [Finding]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(Covance"

Phrase: ")"

Phrase: "at 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: ":"

Phrase: "1000 dilution with 418 h incubation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079240:Dilution [Laboratory Procedure]
   753   C1948037:Dilution [Functional Concept]
Processing 00000000.tx.65: HRP-conjugated anti-mouse antibody (Amersham Biosciences) at 1:2000 dilution was then added to blots, and antibody was detected using ECL blotting reagents (Amersham Biosciences) and Hyperfilm ECL (Amersham Biosciences). 

Phrase: "HRP-conjugated anti-mouse antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Amersham Biosciences"

Phrase: ")"

Phrase: "at 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: ":"

Phrase: "2000 dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "added to blots,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1524062:Added [Functional Concept]
   756 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ECL blotting reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Amersham Biosciences"

Phrase: ")"

Phrase: "and"

Phrase: "Hyperfilm ECL (Amersham Biosciences"

Phrase: ")."
Processing 00000000.tx.66: Blots were stripped and then reprobed for -tubulin (Sigma) at 1:1000 dilution. 

Phrase: "Blots"

Phrase: "were"

Phrase: "stripped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1321564:Strip [Medical Device]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "reprobed for -tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C2937342:tubulin [Cell Component]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "at 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: ":"

Phrase: "1000 dilution."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]
Processing 00000000.tx.67: Immunogold Labeling for Electron MicroscopyCells were induced with 2 g/ml doxycycline for 48 h. 

Phrase: "Immunogold Labeling for Electron MicroscopyCells"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C1167624:Labeling [Mental Process]
   760   C1947902:Labeling [Manufactured Object]
   760   C2827499:Labeling [Governmental or Regulatory Activity]
   726 E C0181496:Label [Manufactured Object]

Phrase: "were"

Phrase: "induced with 2 g/ml doxycycline"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C1300565:g/mL [Quantitative Concept]
   783 E C1637390:mL/g [Quantitative Concept]
   753   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   753   C0205263:Induced [Functional Concept]
   753   C0439267:g% [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]

Phrase: "for 48 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.68: The cells were fixed in situ with 2% formaldehyde and 0.05% glutaraldehyde in 0.1 M PIPES buffer and harvested by scraping. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "fixed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231441:Fixed [Finding]
  1000   C0443218:Fixed [Qualitative Concept]
  1000   C2827483:Fixed [Body Substance]

Phrase: "in situ with 2% formaldehyde"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C0444498:In situ [Spatial Concept]

Phrase: "and"

Phrase: "0.05% glutaraldehyde in 0.1 M PIPES buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0017814:Glutaraldehyde [Biomedical or Dental Material,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "harvested by scraping."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0184933:Scraping [Therapeutic or Preventive Procedure]
   756 E C0444082:scrape [Body Substance]
   756   C1512335:Harvest [Health Care Activity]
Processing 00000000.tx.69: The cells were incubated in 0.1 M PIPES buffer containing 5% bovine serum albumin and 20% polypropylene glycol, concentrated by centrifugation at 2000 rpm in a Hermle Z 160 M centrifuge (Hermle Labortechnik), and the supernatant was removed. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated in 0.1 M PIPES buffer"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0071109:PIPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
   748   C1439852:Incubated [Laboratory Procedure]
   714 E C1709545:PIPE [Pharmacologic Substance]
   714 E C2828033:Pipe [Manufactured Object]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5% bovine serum albumin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   861   C0728877:serum albumin [Laboratory or Test Result]
   812   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0007452:Bovine [Mammal]
   812   C0229671:Serum [Body Substance]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "20% polypropylene glycol,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0071666:polypropylene glycol [Organic Chemical,Pharmacologic Substance]
   827   C0017945:Glycol [Organic Chemical]
   827   C0017951:Glycol [Organic Chemical]
   827   C0032582:Polypropylene [Biomedical or Dental Material,Organic Chemical]

Phrase: "concentrated by centrifugation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C1880165:Concentrated [Biomedical or Dental Material]
   756 E C1880310:Concentrate [Manufactured Object]
   756 E C2003864:Concentrate [Substance]

Phrase: "at 2000 rpm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0582523:rpm [Quantitative Concept]

Phrase: "in a Hermle Z 160 M centrifuge"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0179834:centrifuge [Medical Device]

Phrase: "(Hermle Labortechnik"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "removed."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]
Processing 00000000.tx.70: Small droplets (5 l) of the cells were mounted onto aluminum foil and quench-frozen by plunging them into melting propane cooled in liquid nitrogen. 

Phrase: "Small droplets"

Phrase: "(5 l) of the cells"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C2348935:.5 L [Quantitative Concept]
   797   C0347983:cells/L [Quantitative Concept]
   781 E C0022827:cell l [Cell]

Phrase: "were"

Phrase: "mounted onto aluminum foil"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C0449878:mounted [Finding]
   770   C1551385:Foil [Manufactured Object]
   770   C1705857:Foil [Manufactured Object]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   737 E C0181909:Mount [Medical Device]

Phrase: "and"

Phrase: "quench"

Phrase: "-"

Phrase: "frozen by plunging"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0016701:Frozen [Natural Phenomenon or Process]
   790   C0677542:Frozen [Functional Concept]
   756   C1882408:PLUNGE [Phenomenon or Process]

Phrase: "them into melting propane"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033434:Propane [Organic Chemical]
   770   C0599882:Melting [Natural Phenomenon or Process]

Phrase: "cooled in liquid nitrogen."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0260055:Liquid nitrogen [Element, Ion, or Isotope]
   833   C1550121:Liquid nitrogen [Intellectual Product]
   770   C0028158:Nitrogen [Element, Ion, or Isotope]
   770   C0302908:Liquid [Substance]
   770   C1304698:Liquid [Finding]
   770   C1546699:Liquid NOS [Intellectual Product]
   770   C1550581:nitrogen [Human-caused Phenomenon or Process]
   770   C1561501:Liquid NOS [Substance]
   737   C1548792:Cool [Qualitative Concept]
Processing 00000000.tx.71: After freezing, the cells were transferred into a Leica AFS freeze substitution unit in vials of frozen, dry methanol, containing 0.5% uranyl acetate. 

Phrase: "After freezing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016701:Freezing [Natural Phenomenon or Process]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transferred into a Leica AFS freeze substitution unit"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   770   C0162551:Freeze Substitution [Laboratory Procedure]
   744   C0016701:Freeze [Natural Phenomenon or Process]
   744   C0348011:transferred [Functional Concept]
   744   C0439148:Unit [Quantitative Concept]
   744   C1519795:Unit [Quantitative Concept]
   744   C1555721:Substitution [Idea or Concept]
   744   C1704753:Unit [Manufactured Object]
   744   C1706204:Substitution [Activity]
   744   C1880519:Unit [Quantitative Concept]
   711 E C0040671:Transfer [Mental Process]
   711 E C1705822:Transfer [Activity]

Phrase: "in vials"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0184301:vials [Medical Device]
  1000   C1533199:Vials [Quantitative Concept]
   966 E C1706497:VIAL [Medical Device]

Phrase: "of frozen, dry methanol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.5% uranyl acetate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0077854:uranyl acetate [Organic Chemical,Pharmacologic Substance]
   812   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.72: They were maintained at 90 C for 24 h followed by 24 h at 70 C and another 24 h at 50 C. 

Phrase: "They"

Phrase: "were"

Phrase: "maintained at 90 C"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0439083:>90 [Quantitative Concept]
   770   C0439087:<90 [Quantitative Concept]
   770   C1314677:Maintained [Functional Concept]
   737 E C0024501:Maintain [Activity]

Phrase: "for 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "followed by 24 h"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "at 70 C"

Phrase: "and"

Phrase: "another 24 h at 50 C."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.73: They were infiltrated with Lowicryl HM20 over 3 days and polymerized by irradiation with UV light for 48 h. 

Phrase: "They"

Phrase: "were"

Phrase: "infiltrated with Lowicryl HM20"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0332448:infiltrated [Pathologic Function]
   737 E C1546677:Infiltrate [Intellectual Product]
   737 E C1549537:Infiltrate [Functional Concept]

Phrase: "over 3 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442459:3 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "and"

Phrase: "polymerized by irradiation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0314672:Polymerized [Phenomenon or Process]
   790   C1282930:Irradiation [Natural Phenomenon or Process]
   790   C1522449:irradiation [Therapeutic or Preventive Procedure]

Phrase: "with UV light"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0041625:UV Light [Natural Phenomenon or Process]
           UV
   861   C0023693:Light [Natural Phenomenon or Process]
   861   C1306462:Light [Functional Concept]
   861   C1881376:Light [Qualitative Concept]
   861   C1961129:uV [Quantitative Concept]

Phrase: "for 48 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.74: Thin sections were cut using a Leica Ultracut S and mounted on Formvar-coated nickel grids. 

Phrase: "Thin sections"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   966   C0026040:thin section [Laboratory Procedure]
   861   C0205168:Thin [Qualitative Concept]
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]
   789 E C0039870:Thinness [Finding]

Phrase: "were"

Phrase: "cut"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0000925:Cut [Injury or Poisoning]
  1000   C1883724:CUT [Phenomenon or Process]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Leica Ultracut S"

Phrase: "and"

Phrase: "mounted on Formvar-coated nickel grids."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   753   C0028013:nickel [Biologically Active Substance,Element, Ion, or Isotope]
   753   C0449878:mounted [Finding]
   753   C0950318:Formvar [Hazardous or Poisonous Substance,Organic Chemical]
   753   C1522408:Coated [Qualitative Concept]
   753   C2348274:Nickel [Element, Ion, or Isotope]
   719 E C0181909:Mount [Medical Device]
   719 E C0453946:Coat [Manufactured Object]
   719   C1415284:GRID [Gene or Genome]
   719   C2348395:Grid [Medical Device]
   719   C2825313:Grid [Manufactured Object]
   719 E C2987482:Coat [Body Part, Organ, or Organ Component]
Processing 00000000.tx.75: The sections were incubated overnight in mouse anti-HA primary antibodies (Covance), diluted 1:5 in Tris-buffered saline at pH 7.4 containing 0.1% Tween 20, 0.1% Triton-X-100, 0.5% fetal calf serum, and 10% normal goat serum. 

Phrase: "The sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "overnight in mouse anti-HA primary antibodies"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   774   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0025914:Mouse [Mammal]
   748   C0025929:mouse [Mammal]
   748   C0026809:Mouse [Mammal]
   748   C0205225:Primary [Qualitative Concept]
   748   C0439583:Overnight [Temporal Concept]
   748   C0439631:Primary [Therapeutic or Preventive Procedure]
   714 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Covance"

Phrase: ")"

Phrase: ","

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "5 in Tris-buffered saline"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0036082:Saline [Substance]
   760   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   760   C0439084:>5 [Quantitative Concept]
   760   C0728893:+5 [Quantitative Concept]
   760   C0814229:TRI [Intellectual Product]

Phrase: "at pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.1% Tween 20,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   833 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   812   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   756 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "0.1% Triton-X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: "0.5% fetal calf serum,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   804   C0015965:Fetal [Embryonic Structure]
   804   C0229671:Serum [Body Substance]
   804   C0230445:Calf [Body Location or Region]
   804   C0521457:Fetal [Functional Concept]
   804   C1305418:Calf [Body Part, Organ, or Organ Component]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]
   748 E C0626053:sural [Pharmacologic Substance]

Phrase: "and"

Phrase: "10% normal goat serum."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   812   C0018019:goat [Mammal]
   812   C0205307:Normal [Qualitative Concept]
   812   C0229671:Serum [Body Substance]
   812   C0439166:% normal [Quantitative Concept]
   812   C1265549:goat [Mammal]
   812   C1510458:Goat [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   812   C2347086:% Normal [Quantitative Concept]
Processing 00000000.tx.76: The sections were washed six times in Tris-buffered saline and incubated with goat anti-mouse immunoglobulins conjugated to 10-nm gold particles (British Biocell), diluted 1:100 in the diluent for the primary antibody at pH 8.5 without added goat serum for 1 h (25). 

Phrase: "The sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "six times in Tris-buffered saline"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "incubated with goat anti-mouse immunoglobulins"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   753   C0018019:goat [Mammal]
   753   C0021027:Immunoglobulins [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C0202081:Immunoglobulins NOS [Laboratory Procedure]
   753   C1265549:goat [Mammal]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1510458:Goat [Mammal]
   719 E C1621846:immunoglobulin [Molecular Function]

Phrase: "conjugated to 10-nm gold particles"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0018026:Gold [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0312860:NM [Cell Function]
   753   C0522529:Conjugated [Spatial Concept]
   753   C0597177:particles [Chemical Viewed Structurally]
   753   C1304897:Gold [Functional Concept]
   719 E C0301869:Conjugate [Immunologic Factor]

Phrase: "(British Biocell"

Phrase: ")"

Phrase: ","

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "100 in the diluent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1875022:DILUENT [Biomedical or Dental Material]

Phrase: "for the primary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "at pH 8.5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "without added goat serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0229671:Serum [Body Substance]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "for 1 h (25"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0247683:H 25 [Organic Chemical,Pharmacologic Substance]
   901   C0700308:1 H [Element, Ion, or Isotope]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.77: They were rinsed six times in Tris-buffered saline and twice in deionized water and stained with uranyl acetate and lead citrate before viewing in a Philips CM100 transmission electron microscope.  

Phrase: "They"

Phrase: "were"

Phrase: "rinsed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1701810:Rinse [Functional Concept]
   966   C1882955:Rinse [Activity]

Phrase: "six times in Tris-buffered saline"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "twice in deionized water"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   770   C0599638:WATER [Substance]
   770   C1550678:Water [Inorganic Chemical]
   770   C1720725:Twice [Intellectual Product]
   770   C1948050:Twice [Quantitative Concept]

Phrase: "and"

Phrase: "stained with uranyl acetate"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   865   C2984971:URANYL ACETATE STAIN [Laboratory Procedure]
   833   C0077854:uranyl acetate [Organic Chemical,Pharmacologic Substance]
   770   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "lead citrate before viewing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0008857:Citrate [Organic Chemical]
   770   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]

Phrase: "in a Philips CM100 transmission electron microscope."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   884   C0262880:Transmission Electron Microscope [Medical Device]
   840   C0181845:Electron Microscope [Medical Device]
   804   C0013852:Electron [Quantitative Concept]
   804   C0040722:transmission [Idea or Concept]
   804   C0181839:Microscope [Medical Device]
   804   C0242781:Transmission [Pathologic Function]
   804   C1521797:Transmission [Natural Phenomenon or Process]
   804   C1706379:Microscope [Medical Device]
   804   C3463986:Electron [Bird]
   733 E C0013850:Electronic [Manufactured Object]
   733 E C1547561:Electronic [Idea or Concept]
Processing 00000000.tx.78: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Establishment of Inducible -Synuclein Cell LinesWe established stable, inducible lines for human wild-type, A30P, and A53T -synuclein in PC12 (rat phaeochromocytoma) cells using the Tet-On system, where addition of doxycycline switches on transgene expression. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Establishment of Inducible -Synuclein Cell LinesWe"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "stable, inducible lines for human wild-type, A30P,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0205132:lines [Spatial Concept]
   711 E C1550648:Line [Substance]
   711 E C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "A53T -synuclein in PC12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(rat phaeochromocytoma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031511:Pheochromocytoma [Neoplastic Process]
   861   C2697417:PHEOCHROMOCYTOMA [Gene or Genome]

Phrase: ")"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Tet-On system,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515333:Tet [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "where addition of doxycycline switches"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1883712:Addition [Functional Concept]

Phrase: "on transgene expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
   861   C0282641:Transgene [Gene or Genome]
Processing 00000000.tx.79: We selected two different clonal lines for each form of -synuclein, on the basis of low background transgene expression and high inducibility and tested these independent lines in all our experiments. 

Phrase: "We"

Phrase: "selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "two different clonal lines for each form of -synuclein,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   742   C0205132:lines [Spatial Concept]
   708 E C1550648:Line [Substance]
   708 E C1552960:Line [Quantitative Concept]

Phrase: "on the basis of low background transgene expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   812   C0282641:Transgene [Gene or Genome]

Phrase: "and"

Phrase: "high inducibility"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   789   C0205263:Inducible [Functional Concept]
   789   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "these independent lines in all"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0205132:lines [Spatial Concept]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]

Phrase: "our experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.80: We initially looked at -synuclein localization in our induced cells. 

Phrase: "We initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "looked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0233426:look [Organism Attribute]

Phrase: "at -synuclein localization in our induced cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1660153:cell localization [Biologic Function]
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]
Processing 00000000.tx.81: We found that -synuclein was evenly distributed across the cells, often with a vesicular pattern of staining (Fig. 1A). 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "evenly"

Phrase: "distributed across the cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1704711:Distributed [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "often with a vesicular pattern of staining"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   814   C0449778:Pattern of staining [Spatial Concept]
   748   C0205378:Vesicular [Qualitative Concept]
   748   C0332183:Often [Temporal Concept]
   748   C0449774:Pattern [Spatial Concept]
   748   C0487602:Staining [Laboratory Procedure]
   748   C1704680:Staining [Finding]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.82: The diffuse cytoplasmic and nuclear localization of -synuclein was similar to previous observation with this protein in PC12 cells (18). 

Phrase: "The diffuse cytoplasmic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010834:Cytoplasmic [Cell Component]
   861   C0521449:Cytoplasmic [Body Location or Region]

Phrase: "and"

Phrase: "nuclear localization of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "similar to previous observation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "with this protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.83: The image shown is representative of -synuclein localization in all our cell lines expressing wild-type, A30P, and A53T with either mitotic or differentiated cells, induced for 2, 6, or 10 days. 

Phrase: "The image"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1704254:Image [Intellectual Product]
  1000   C1704922:Image [Entity]
  1000   C3542466:Image [Intellectual Product]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "is"

Phrase: "representative of -synuclein localization in all"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "our cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "expressing"

Phrase: "wild-type, A30P,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "and"

Phrase: "A53T with either mitotic"

Phrase: "or"

Phrase: "differentiated cells,"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   861   C0007589:Differentiated [Cell Function]
   861   C0007634:Cells [Cell]
   861   C0205615:Differentiated [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789 E C1511938:Differentiation [Clinical Attribute]
   789 E C2945687:Differentiation [Functional Concept]

Phrase: "induced for 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205263:Induced [Functional Concept]

Phrase: "6,"

Phrase: "or"

Phrase: "10 days."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1547061:10 days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.84: At the light microscope level, it was unclear whether the vesicular structures were aggregates. 

Phrase: "At the light microscope level,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]
   734   C0491970:Light Microscope [Medical Device]

Phrase: "it"

Phrase: "was"

Phrase: "unclear"

Phrase: "whether"

Phrase: "the vesicular structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:structures [Spatial Concept]

Phrase: "were"

Phrase: "aggregates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:aggregates [Qualitative Concept]
Processing 00000000.tx.85: We did not see very large aggregates characteristic of polyglutamine and polyalanine expansions (e.g. Ref. 26) for either wild-type, A30P, or A53T, even after expression of -synuclein for 10 days. 

Phrase: "We"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "very large aggregates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205418:aggregates [Qualitative Concept]
   734   C0450093:Very large [Finding]

Phrase: "characteristic of polyglutamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1521970:Characteristic [Qualitative Concept]

Phrase: "and"

Phrase: "polyalanine expansions"

Phrase: "("

Phrase: "e.g. Ref. 26"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")"

Phrase: "for either wild-type, A30P,"

Phrase: "or"

Phrase: "A53T,"

Phrase: "even"

Phrase: "after"

Phrase: "expression of -synuclein for 10 days."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.86: The staining for -synuclein in uninduced cells was below the level of detection when analyzed with confocal microscopy using the same settings that gave clear signals for induced cells (Fig. 1B). 

Phrase: "The staining for -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]

Phrase: "in uninduced cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "was below the level of detection"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0043194:WAS [Disease or Syndrome]
   753   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1421478:WAS [Gene or Genome]
   753   C1511790:Detection [Therapeutic or Preventive Procedure]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "when"

Phrase: "analyzed with confocal microscopy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0242842:Microscopy, Confocal [Laboratory Procedure]
   770   C0026018:Microscopy [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the same settings"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0542559:setting [Functional Concept]
   827   C1318139:{Setting} [Quantitative Concept]

Phrase: "that"

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "clear signals for induced cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0037083:cell signals [Cell Function]
   726   C1710082:Signal [Phenomenon or Process]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.87: However, -synuclein immunoreactivity in the uninduced cells was observed when the gain was increased; 

Phrase: "However, -"

Phrase: "synuclein immunoreactivity in the uninduced cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "when"

Phrase: "the gain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517378:Gain [Quantitative Concept]

Phrase: "was"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.88: this staining is likely to reflect predominantly endogenous -synuclein in the cells, since there is minimal leakiness of transgene expression in uninduced cells (Fig. 2). 

Phrase: "this staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "predominantly endogenous -synuclein in the cells,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "since"

Phrase: "there"

Phrase: "is"

Phrase: "minimal leakiness of transgene expression"

Phrase: "in uninduced cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.89: We also examined cell death by fluorescence-activated cell sorter analysis and inspection of nuclear morphology after DAPI staining. 

Phrase: "We also examined cell death by fluorescence-activated cell sorter analysis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   756   C0007587:Cell Death [Cell Function]
   754   C1140606:SORTER, CELL [Medical Device]
   738   C0007634:Cell [Cell]
   738   C0011065:Death [Organism Function]
   738   C1269647:Cell [Cell]
   738   C1306577:Death, NOS [Finding]
   738   C1704653:Cell [Medical Device]
   738   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "inspection of nuclear morphology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0199219:Inspection [Functional Concept]

Phrase: "after DAPI staining."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]
Processing 00000000.tx.90: We did not find a significant change in numbers of dead cells after induction of -synuclein expression in any of the lines expressing wild-type, A30P, or A53T (data not shown). 

Phrase: "We"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "a significant change in numbers of dead cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0392747:Change [Functional Concept]
   744   C0443172:change [Quantitative Concept]
   744   C1705241:Change [Quantitative Concept]

Phrase: "after induction of -synuclein expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in any"

Phrase: "of the lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205132:lines [Spatial Concept]
   966 E C1550648:Line [Substance]
   966 E C1552960:Line [Quantitative Concept]

Phrase: "expressing"

Phrase: "wild-type, A30P,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "or"

Phrase: "A53T"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.91: In both cycling and differentiated cells, cell death was <10% at all times studied up to 10 days of induction (assessment by DAPI staining for wild-type, A30P, or A53T). 

Phrase: "In both cycling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1511572:Cycle [Temporal Concept]

Phrase: "and"

Phrase: "differentiated cells,"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   861   C0007589:Differentiated [Cell Function]
   861   C0007634:Cells [Cell]
   861   C0205615:Differentiated [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789 E C1511938:Differentiation [Clinical Attribute]
   789 E C2945687:Differentiation [Functional Concept]

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was <"

Phrase: "10% at all times"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0040223:times [Temporal Concept]
   770   C1632851:Times [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "studied up to 10 days of induction"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   778   C1547061:10 days [Temporal Concept]
   748   C0205263:Induction [Functional Concept]
   748   C0439228:days [Temporal Concept]
   748   C0857127:induction [Therapeutic or Preventive Procedure]
   741   C2826182:Study Day [Temporal Concept]
   714 E C0332173:/day [Temporal Concept]
   714 E C0439505:/day [Temporal Concept]
   714   C0557651:Study [Manufactured Object]
   714   C2603343:Study [Research Activity]

Phrase: "(assessment by DAPI staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1261322:Assessment [Health Care Activity]
   770   C1516048:Assessment [Activity]

Phrase: "for wild-type, A30P,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "or"

Phrase: "A53T"

Phrase: ")."
Processing 00000000.tx.92: View larger version (12K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(12K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.93: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.94: -Synuclein is evenly distributed across the cells, often with a vesicular pattern of staining. 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "evenly"

Phrase: "distributed across the cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1704711:Distributed [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "often with a vesicular pattern of staining."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   814   C0449778:Pattern of staining [Spatial Concept]
   748   C0205378:Vesicular [Qualitative Concept]
   748   C0332183:Often [Temporal Concept]
   748   C0449774:Pattern [Spatial Concept]
   748   C0487602:Staining [Laboratory Procedure]
   748   C1704680:Staining [Finding]
Processing 00000000.tx.95: A, immunofluoresence image of stable, inducible PC12 cells expressing wild-type -synuclein. 

Phrase: "A,"

Phrase: "immunofluoresence image of stable, inducible PC12 cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1704254:Image [Intellectual Product]
   748   C1704922:Image [Entity]
   748   C3542466:Image [Intellectual Product]

Phrase: "expressing"

Phrase: "wild-type -synuclein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.96: The cells were differentiated with 100 ng/ml NGF in low serum medium for 5 days and then induced to express wild-type -synuclein with 2 g/ml doxycycline. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "differentiated with 100 ng/ml NGF"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0439275:ng/mL [Quantitative Concept]
   753   C0007589:Differentiated [Cell Function]
   753   C0205615:Differentiated [Qualitative Concept]
   753   C0439526:/mL [Quantitative Concept]
   753   C1417719:NGF [Gene or Genome]

Phrase: "in low serum medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "for 5 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442466:5 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "wild-type -synuclein with 2 g/ml doxycycline."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.97: The cells were treated with doxycycline for 10 days before fixing and staining for -synuclein. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with doxycycline"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]
   734 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "for 10 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1547061:10 days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "before fixing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0231441:Fix [Finding]

Phrase: "and"

Phrase: "staining for -synuclein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0487602:Staining [Laboratory Procedure]
   790   C1704680:Staining [Finding]
Processing 00000000.tx.98: B, a selection of cells from the same experiment as in A comparing immunofluorescence signals in induced (I) and uninduced (U) cells. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "a selection of cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0036576:selection [Genetic Function]

Phrase: "from the same experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: "as in A comparing immunofluorescence"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0016318:Immunofluorescence [Laboratory Procedure]
   760   C0079603:Immunofluorescence [Laboratory Procedure]
   726   C1707455:Compare [Activity]
   704 E C0282648:Direct immunofluorescence [Laboratory Procedure]

Phrase: "signals in induced (I)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205263:Induced [Functional Concept]
   790   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "uninduced (U) cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.99: When uninduced cells were imaged by confocal microscopy using the same settings used for the induced cells, no signals were detected. 

Phrase: "When"

Phrase: "uninduced cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "imaged by confocal microscopy"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0242842:Microscopy, Confocal [Laboratory Procedure]
   770   C0026018:Microscopy [Laboratory Procedure]
   737   C1704254:Image [Intellectual Product]
   737   C1704922:Image [Entity]
   737   C3542466:Image [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the same settings"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0542559:setting [Functional Concept]
   827   C1318139:{Setting} [Quantitative Concept]

Phrase: "used for the induced cells,"
Meta Candidates (Total=10; Excluded=6; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0205263:Induced [Functional Concept]
   760   C1273517:used [Finding]
   760   C3282337:Cells [Cell]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1947944:Use [Intellectual Product]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "no signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "detected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.100: However, staining was detected when the gain settings were increased (U+).  

Phrase: "However,"

Phrase: "staining"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "when"

Phrase: "the gain settings"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0542559:setting [Functional Concept]
   827   C1318139:{Setting} [Quantitative Concept]

Phrase: "were"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "(U+"

Phrase: ")."
Processing 00000000.tx.101: View larger version (16K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.102: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.103: Degradation of -synuclein after expression is switched off in the inducible cell lines. 

Phrase: "Degradation of -synuclein after expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "switched off"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1707719:Switch [Manufactured Object]

Phrase: "in the inducible cell lines."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.104: Western blot analysis of total exogenous human -synuclein in the inducible PC12 cell lines. 

Phrase: "Western blot analysis of total exogenous human -synuclein"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   800   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   770   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]
   744   C1705493:Western [Spatial Concept]

Phrase: "in the inducible PC12 cell lines."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0007600:Cell lines [Cell]
   861   C0085262:PC12 Cell [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.105: Cells were left uninduced (U) or induced with 2 g/ml doxycycline for 24 h (I) or induced for 24 h and then washed to remove doxycycline and left for a further 72 h (OFF) in medium. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "uninduced"

Phrase: "(U"

Phrase: ")"

Phrase: "or"

Phrase: "induced with 2 g/ml doxycycline"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C1300565:g/mL [Quantitative Concept]
   783 E C1637390:mL/g [Quantitative Concept]
   753   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   753   C0205263:Induced [Functional Concept]
   753   C0439267:g% [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]

Phrase: "for 24 h (I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205263:Induced [Functional Concept]

Phrase: ")"

Phrase: "or"

Phrase: "induced for 24 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0205263:Induced [Functional Concept]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "doxycycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   944 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "left for a further 72 h ("
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0205091:Left [Spatial Concept]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   753   C1517331:Further [Spatial Concept]
   753   C1552822:left [Functional Concept]
   719 E C0205108:far [Spatial Concept]

Phrase: "OFF"

Phrase: ")"

Phrase: "in medium."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0009458:Medium [Intellectual Product]
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]
Processing 00000000.tx.106: The top panels show the -synuclein band detected with an anti-HA antibody, and the bottom panels show -tubulin as a loading control. 

Phrase: "The top panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the -synuclein band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]

Phrase: "detected with an anti-HA antibody,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "the bottom panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "show -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "tubulin as a loading control."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C2937342:tubulin [Cell Component]
Processing 00000000.tx.107: Note that where the uninduced and induced lanes appear as separate gel "strips," these were derived from non-adjacent lanes from the same exposure of blots from single gels where lysates from uninduced and induced cells were loaded; 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that where"

Phrase: "the uninduced"

Phrase: "and"

Phrase: "induced lanes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "appear as separate gel ""strips,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C0443299:Separate [Spatial Concept]
   760   C0700364:APPEAR [Qualitative Concept]
   760   C1321564:strips [Medical Device]
   760   C1382104:Gel [Substance]

Phrase: """"

Phrase: "these"

Phrase: "were"

Phrase: "derived from non-adjacent lanes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205117:Adjacent [Spatial Concept]
   760   C1441547:Derived [Qualitative Concept]
   760   C1518422:Non [Functional Concept]
   760   C3245521:derived [Idea or Concept]
   726   C1708639:Lane [Spatial Concept]

Phrase: "from the same exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0274281:Exposure, NOS [Injury or Poisoning]
   861   C0332157:Exposure [Clinical Attribute]

Phrase: "of blots"

Phrase: "from single gels where lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1881488:Lysate [Physical Object]

Phrase: "from uninduced"

Phrase: "and"

Phrase: "induced cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "loaded"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708715:Loaded [Activity]
   966 E C1550025:Load [Idea or Concept]
   966 E C1704782:Load [Manufactured Object]

Phrase: ";"
Processing 00000000.tx.108: intervening lanes were excised to simplify presentation. 

Phrase: "intervening lanes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "were"

Phrase: "excised"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "simplify"

Phrase: "presentation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449450:Presentation [Idea or Concept]
Processing 00000000.tx.109: WT, wild-type.  

Phrase: "WT, wild-type."
Processing 00000000.tx.110: In this study, we have assayed -synuclein levels by Western blotting using an anti-HA antibody to enable specific detection of the transgene products. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "have"

Phrase: "assayed -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "synuclein levels by Western blotting"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an anti-HA antibody to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "enable"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562342:enable [Mental Process]
  1000   C1171285:enable [Mental Process]

Phrase: "specific detection of the transgene products."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1511790:Detection [Therapeutic or Preventive Procedure]
Processing 00000000.tx.111: All blots in this paper are representative and were performed at least twice with each clonal cell line. 

Phrase: "All blots in this paper"

Phrase: "are"

Phrase: "representative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Representative [Activity]

Phrase: "and"

Phrase: "were"

Phrase: "performed at least twice"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0884358:Performed [Functional Concept]
   770   C1720725:Twice [Intellectual Product]
   770   C1948050:Twice [Quantitative Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "with each clonal cell line."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C0007600:Cell Line [Cell]
   865   C0009013:Clone Cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.112: We used our cell model to switch on expression of -synuclein with doxycycline and then switch off expression by removing doxycycline from the medium, to follow -synuclein degradation. 

Phrase: "We"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "our cell model to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3161035:Model [Intellectual Product]

Phrase: "switch on expression of -synuclein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C1707719:Switch [Manufactured Object]

Phrase: "with doxycycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   944 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "switch off expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]
   790   C1707719:Switch [Manufactured Object]

Phrase: "by removing doxycycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   805 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "from the medium,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "follow -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: "synuclein degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]
Processing 00000000.tx.113: Significantly lower levels of -synuclein were observed 72 h after expression was switched off, compared with the time point at which doxycycline was removed (Fig. 2). 

Phrase: "Significantly lower levels of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "72 h after expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "was"

Phrase: "switched off,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1707719:Switch [Manufactured Object]

Phrase: "compared with the time point"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C2348792:Time Point [Temporal Concept]
   760   C0040223:Time [Temporal Concept]
   760   C1552961:Point [Quantitative Concept]
   760   C1707455:Compared [Activity]
   760   C2347617:point [Quantitative Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "at which doxycycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   944 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.114: -Synuclein Is Degraded by the Proteasome in Our Cell ModelWe switched on -synuclein expression for 24 h, then removed doxycycline and added the proteasome inhibitors epoxomicin or lactacystin for 48 h. 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Is"

Phrase: "Degraded by the Proteasome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1325620:proteasome [Cell Component]
   770   C1752727:Proteasome [Molecular Function]
   770   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "in Our Cell ModelWe"

Phrase: "switched"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707719:Switch [Manufactured Object]

Phrase: "on -synuclein expression for 24 h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "then removed doxycycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   771 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "the proteasome inhibitors epoxomicin"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0656383:epoxomicin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   734   C1443643:Proteasome Inhibitors [Pharmacologic Substance]
   734   C2266856:Proteasome Inhibitors [Molecular Function]
   701 E C3537238:Proteasome Inhibitor [Pharmacologic Substance]

Phrase: "or"

Phrase: "lactacystin for 48 h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0125179:lactacystin [Antibiotic,Organic Chemical]
Processing 00000000.tx.115: We consistently saw an increase in -synuclein levels with treatment with the proteasome inhibitors epoxomicin or lactacystin, in both cycling and differentiated cells in all cell lines (Fig. 3). 

Phrase: "We consistently"

Phrase: "saw"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0183089:SAW [Medical Device]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "an increase in -synuclein levels with treatment"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "with the proteasome inhibitors epoxomicin"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0656383:epoxomicin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   734   C1443643:Proteasome Inhibitors [Pharmacologic Substance]
   734   C2266856:Proteasome Inhibitors [Molecular Function]
   701 E C3537238:Proteasome Inhibitor [Pharmacologic Substance]

Phrase: "or"

Phrase: "lactacystin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0125179:lactacystin [Antibiotic,Organic Chemical]

Phrase: "in both cycling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1511572:Cycle [Temporal Concept]

Phrase: "and"

Phrase: "differentiated cells in all cell lines"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   783   C0007600:cells lines [Cell]
   753   C0007589:Differentiated [Cell Function]
           cells differentiation
   753   C0007634:Cells [Cell]
   753   C0205615:Differentiated [Qualitative Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.116: We used both inhibitors as recent reports have shown that lactacystin also inhibits cathepsin A activity of the lysosome and thus may not be proteasome-specific (27, 28). 

Phrase: "We"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "both inhibitors as recent reports"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0243077:inhibitors [Chemical Viewed Functionally]
   726 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that lactacystin also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0125179:lactacystin [Antibiotic,Organic Chemical]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "cathepsin A activity of the lysosome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "thus"

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "proteasome-specific"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205369:Specific [Qualitative Concept]
   861   C1552740:specific [Intellectual Product]

Phrase: "(27,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.117: Addition of these drugs did not cause increased cell death or overt aggregate formation. 

Phrase: "Addition of these drugs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "increased cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "overt aggregate formation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
Processing 00000000.tx.118: View larger version (23K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(23K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.119: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.120: The proteasome inhibitors epoxomicin and lactacystin disrupt -synuclein degradation. 

Phrase: "The proteasome inhibitors epoxomicin"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0656383:epoxomicin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   734   C1443643:Proteasome Inhibitors [Pharmacologic Substance]
   734   C2266856:Proteasome Inhibitors [Molecular Function]
   701 E C3537238:Proteasome Inhibitor [Pharmacologic Substance]

Phrase: "and"

Phrase: "lactacystin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0125179:lactacystin [Antibiotic,Organic Chemical]

Phrase: "disrupt -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "synuclein degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]
Processing 00000000.tx.121: Cells were induced with 2 g/ml doxycycline for 24 h and then washed twice to remove doxycycline and switch off -synuclein expression. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "induced with 2 g/ml doxycycline"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C1300565:g/mL [Quantitative Concept]
   783 E C1637390:mL/g [Quantitative Concept]
   753   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   753   C0205263:Induced [Functional Concept]
   753   C0439267:g% [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]

Phrase: "for 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720725:Twice [Intellectual Product]
   861   C1948050:Twice [Quantitative Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "doxycycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   944 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "switch off -synuclein expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707719:Switch [Manufactured Object]
Processing 00000000.tx.122: The cells were then treated with 10 M epoxomicin (epoxo) or 10 M lactacystin (lact) or appropriate carrier control (c) water for lactacystin, Me2SO for epoxomicin, in tissue culture medium for 48 h. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "treated with 10 M epoxomicin (epoxo)"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C0656383:epoxomicin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "10 M lactacystin (lact)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0125179:lactacystin [Antibiotic,Organic Chemical]

Phrase: "or"

Phrase: "appropriate carrier control (c) water for lactacystin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   753   C0599638:WATER [Substance]
   753   C1550678:Water [Inorganic Chemical]

Phrase: "Me2SO for epoxomicin,"

Phrase: "in tissue culture medium"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   901   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   901   C0040284:Tissue culture [Laboratory Procedure]
   827   C0009458:Medium [Intellectual Product]
   827   C0010453:Culture [Idea or Concept]
   827   C0040300:Tissue [Tissue]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C0439536:Medium [Quantitative Concept]
   827   C1547928:Tissue [Intellectual Product]
   827   C1705217:Medium [Substance]
   827   C2242979:Culture [Laboratory Procedure]
   827   C3244283:medium [Intellectual Product]

Phrase: "for 48 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.123: Cell pellets were collected, cells were lysed, and total protein was run on denaturing acrylamide gels. 

Phrase: "Cell pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0993610:pellets [Biomedical or Dental Material]
   827 E C0441436:Pellet [Manufactured Object]
   827 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: ","

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: ","

Phrase: "and"

Phrase: "total protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0555903:Total protein [Laboratory Procedure]
  1000   C1261360:total protein [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]

Phrase: "was"

Phrase: "run on denaturing acrylamide gels."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0017243:Gels [Biomedical or Dental Material]
   771 E C1382104:Gel [Substance]
Processing 00000000.tx.124: -Synuclein was detected using an antibody to the HA tag (top panels), and loading was checked by probing for -tubulin (lower panels). 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an antibody to the HA tag (top panels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "loading"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708715:Loading [Activity]

Phrase: "was"

Phrase: "checked by probing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0419358:Probing, NOS [Diagnostic Procedure]
   790   C1283174:Checked [Activity]

Phrase: "for -tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "(lower panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.125: A, mitotic cells. 

Phrase: "A,"

Phrase: "mitotic cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0230518:Mitotic cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.126: B, cells induced to differentiate with 100 ng/ml NGF for 5 days before adding doxycyline to induce -synuclein expression. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "differentiate with 100 ng/ml NGF"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0439275:ng/mL [Quantitative Concept]
   753   C0205615:differentiate [Qualitative Concept]
   753   C0439526:/mL [Quantitative Concept]
   753   C1417719:NGF [Gene or Genome]

Phrase: "for 5 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442466:5 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "before adding doxycyline to"

Phrase: "induce -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "synuclein expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.127: Note that where the control and treated lanes appear as separate gel strips, these were derived from non-adjacent lanes from the same exposure of blots from single gels where lysates from control and treated cells were loaded; 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that where"

Phrase: "the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "treated lanes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "appear as separate gel strips,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C0443299:Separate [Spatial Concept]
   760   C0700364:APPEAR [Qualitative Concept]
   760   C1321564:strips [Medical Device]
   760   C1382104:Gel [Substance]

Phrase: "these"

Phrase: "were"

Phrase: "derived from non-adjacent lanes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205117:Adjacent [Spatial Concept]
   760   C1441547:Derived [Qualitative Concept]
   760   C1518422:Non [Functional Concept]
   760   C3245521:derived [Idea or Concept]
   726   C1708639:Lane [Spatial Concept]

Phrase: "from the same exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0274281:Exposure, NOS [Injury or Poisoning]
   861   C0332157:Exposure [Clinical Attribute]

Phrase: "of blots"

Phrase: "from single gels where lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1881488:Lysate [Physical Object]

Phrase: "from control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "treated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "loaded"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708715:Loaded [Activity]
   966 E C1550025:Load [Idea or Concept]
   966 E C1704782:Load [Manufactured Object]

Phrase: ";"
Processing 00000000.tx.128: intervening lanes were excised to simplify presentation. 

Phrase: "intervening lanes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "were"

Phrase: "excised"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "simplify"

Phrase: "presentation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449450:Presentation [Idea or Concept]
Processing 00000000.tx.129: WT, wild-type.  

Phrase: "WT, wild-type."
Processing 00000000.tx.130: -Synuclein Is Degraded by AutophagyWe then tested whether -synuclein is also degraded by autophagy using a panel of inhibitors/activators, a strategy we have used previously in the context of polyglutamine/polyalanine expansions. 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Is"

Phrase: "Degraded by AutophagyWe then"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1881707:DEGRADED [Phenomenon or Process]
   770   C1883708:Then [Temporal Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "whether -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "also"

Phrase: "degraded by autophagy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0004391:Autophagy [Cell Function]
   790   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a panel of inhibitors/activators,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0441833:Panel [Idea or Concept]
   760   C1999270:Panel [Intellectual Product]
   760   C3537156:Panel [Manufactured Object]

Phrase: "a strategy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679199:strategy [Mental Process]

Phrase: "we"

Phrase: "have"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "previously in the context of polyglutamine/polyalanine expansions."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0071505:polyalanine [Amino Acid, Peptide, or Protein]
   744   C0384782:polyglutamine [Amino Acid, Peptide, or Protein]
   744   C0449255:Context [Finding]
   744   C0542559:Context [Functional Concept]
Processing 00000000.tx.131: 3-MA is a specific inhibitor of autophagy (20) inhibiting autophagy at the sequestration stage, where a double membrane structure forms around a portion of the cytosol. 

Phrase: "3-MA"

Phrase: "is"

Phrase: "a specific inhibitor of autophagy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(20"

Phrase: ")"

Phrase: "inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "autophagy at the sequestration stage,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0004391:Autophagy [Cell Function]

Phrase: "where"

Phrase: "a double membrane structure forms around a portion of the cytosol."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   738   C0348078:forms [Qualitative Concept]
   738   C0376315:Forms [Manufactured Object]
   704 E C1522492:Form [Functional Concept]
Processing 00000000.tx.132: Bafilomycin A1 (baf A1) is a vacuolar ATPase inhibitor that interferes with the autophagosome-lysosome fusion step (29), and rapamycin is an antifungal macrolide antibiotic that stimulates autophagy. 

Phrase: "Bafilomycin A1 (baf A1)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052919:bafilomycin A1 [Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "a vacuolar ATPase inhibitor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1999216:Inhibitor [Qualitative Concept]
   734   C0379099:Vacuolar ATPase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that"

Phrase: "interferes with the autophagosome-lysosome fusion step"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C0521102:Interferes with [Qualitative Concept]
           Interfere
   748   C0024369:Lysosome [Cell Component]
   748   C0332466:Fusion [Functional Concept]
   748   C0544966:Autophagosome [Cell Component]
   748   C1261552:Step [Conceptual Entity]
   748   C1293131:Fusion [Therapeutic or Preventive Procedure]
   748   C1704379:Step [Functional Concept]
   748   C1705117:Step [Quantitative Concept]
   748   C2825408:Step [Manufactured Object]
   748   C2984253:Lysosome [Functional Concept]

Phrase: "(29"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "rapamycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072980:Rapamycin [Antibiotic,Organic Chemical]

Phrase: "is"

Phrase: "an antifungal macrolide antibiotic"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0003235:Antifungal antibiotic, NOS [Antibiotic]
   901   C0003240:Macrolide Antibiotic [Antibiotic,Organic Chemical]
           Macrolide
   827   C0003232:Antibiotic [Antibiotic]
   827   C0282563:Macrolide [Organic Chemical,Pharmacologic Substance]
   827   C3537143:Macrolide [Pharmacologic Substance]

Phrase: "that"

Phrase: "stimulates"

Phrase: "autophagy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004391:Autophagy [Cell Function]
Processing 00000000.tx.133: To test the role of autophagy on -synuclein clearance in our cell lines, they were induced for 24 h, then doxycycline was removed and the drugs were added for 48 h. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "the role of autophagy on -synuclein clearance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in our cell lines,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "they"

Phrase: "were"

Phrase: "induced for 24 h,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0205263:Induced [Functional Concept]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "then doxycycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   805 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "the drugs"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0013227:Drugs [Pharmacologic Substance]
   966 E C1254351:Drug [Pharmacologic Substance]
   928 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   928 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   900 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "were"

Phrase: "added for 48 h."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1524062:Added [Functional Concept]
   737 E C1883712:Add [Functional Concept]
Processing 00000000.tx.134: The trends we observed were similar in cells treated with drugs for 24 and 72 h (data not shown). 

Phrase: "The trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "were"

Phrase: "similar in cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "treated with drugs"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0013227:Drugs [Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1254351:Drug [Pharmacologic Substance]
   756 E C1292734:TREAT [Functional Concept]
   718 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   718 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]

Phrase: "for 24"

Phrase: "and"

Phrase: "72 h (data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.135: Inhibiting autophagy with 3-MA and baf A1 led to an obvious increase of -synuclein levels in the A53T lines (Fig. 4). 

Phrase: "Inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "autophagy with 3-MA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0004391:Autophagy [Cell Function]

Phrase: "and"

Phrase: "baf A1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052919:bafilomycin A1 [Organic Chemical,Pharmacologic Substance]

Phrase: "led to an obvious increase of -synuclein levels"
Meta Candidates (Total=14; Excluded=9; Pruned=0; Remaining=5)
   750   C0428255:lead levels [Laboratory or Test Result]
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0441889:Levels [Qualitative Concept]
   744   C0442805:Increase [Functional Concept]
   744   C1708698:LED [Manufactured Object]
   734 E C0524167:Lead level [Laboratory Procedure]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C0456079:Level [Classification]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C1522538:Lead [Functional Concept]
   711 E C1547707:Level [Geographic Area]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C2946261:Level [Pharmacologic Substance]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in the A53T lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.136: These inhibitors only induced slight changes, at best, in -synuclein levels in mitotic wild-type and A30P lines (e.g. 3-MA with wild-type). 

Phrase: "These inhibitors only"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "slight changes,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "at best, in -synuclein levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "in mitotic wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1883559:Wild Type [Organism Attribute]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "A30P lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "("

Phrase: "e.g. 3-MA with wild-type"

Phrase: ")."
Processing 00000000.tx.137: Rapamycin, which stimulates autophagy, increased clearance of wild-type, A30P, and A53T -synuclein in mitotic cells (Fig. 4A). 

Phrase: "Rapamycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072980:Rapamycin [Antibiotic,Organic Chemical]

Phrase: "which"

Phrase: "stimulates"

Phrase: "autophagy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004391:Autophagy [Cell Function]

Phrase: "increased clearance of wild-type, A30P,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0449297:Clearance [Qualitative Concept]
   753   C1382187:Clearance [Clinical Attribute]
   753   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "A53T -synuclein in mitotic cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.138: View larger version (18K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.139: 4. 

Phrase: "4."
Processing 00000000.tx.140: -Synuclein is degraded by autophagy. 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "degraded by autophagy."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0004391:Autophagy [Cell Function]
   790   C1881707:DEGRADED [Phenomenon or Process]
Processing 00000000.tx.141: The cells were induced to express -synuclein for 24 h, washed, and then treated with 10 mM 3-MA, 200 nM bafilomycin A1 (baf), 0.2 mg/ml rapamycin (rap), or controls (c) water for 3-MA, Me2SO for bafilomycin A1 and rapamycin, for 48 h. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express -"

Phrase: "synuclein for 24 h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: ","

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "treated with 10 mM 3-MA,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   783   C1883310:10^3 [Quantitative Concept]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "200 nM bafilomycin A1 (baf),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0052919:bafilomycin A1 [Organic Chemical,Pharmacologic Substance]

Phrase: "0.2 mg/ml rapamycin (rap),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0072980:Rapamycin [Antibiotic,Organic Chemical]

Phrase: "or"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "(c"

Phrase: ")"

Phrase: "water for 3-MA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   770   C0599638:WATER [Substance]
   770   C1550678:Water [Inorganic Chemical]

Phrase: "Me2SO for bafilomycin A1"

Phrase: "and"

Phrase: "rapamycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072980:Rapamycin [Antibiotic,Organic Chemical]

Phrase: "for 48 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.142: Total cell lysate was analyzed for -synuclein content, and loading was checked using -tubulin. 

Phrase: "Total cell lysate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "was"

Phrase: "analyzed for -synuclein content,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0423896:Content [Mental Process]
   770   C0456205:Content [Conceptual Entity]
   770   C0936012:Analyzed [Research Activity]

Phrase: "and"

Phrase: "loading"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708715:Loading [Activity]

Phrase: "was"

Phrase: "checked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1283174:Checked [Activity]

Phrase: "using -"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "tubulin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]
Processing 00000000.tx.143: A, mitotic cells; 

Phrase: "A,"

Phrase: "mitotic cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0230518:Mitotic cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.144: B, differentiated cells. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "differentiated cells."
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   861   C0007589:Differentiated [Cell Function]
   861   C0007634:Cells [Cell]
   861   C0205615:Differentiated [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789 E C1511938:Differentiation [Clinical Attribute]
   789 E C2945687:Differentiation [Functional Concept]
Processing 00000000.tx.145: Note that where the control and treated lanes appear as separate gel strips, these were derived from non-adjacent lanes from the same exposure of blots from single gels where lysates from control and treated cells were loaded; 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that where"

Phrase: "the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "treated lanes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "appear as separate gel strips,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C0443299:Separate [Spatial Concept]
   760   C0700364:APPEAR [Qualitative Concept]
   760   C1321564:strips [Medical Device]
   760   C1382104:Gel [Substance]

Phrase: "these"

Phrase: "were"

Phrase: "derived from non-adjacent lanes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205117:Adjacent [Spatial Concept]
   760   C1441547:Derived [Qualitative Concept]
   760   C1518422:Non [Functional Concept]
   760   C3245521:derived [Idea or Concept]
   726   C1708639:Lane [Spatial Concept]

Phrase: "from the same exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0274281:Exposure, NOS [Injury or Poisoning]
   861   C0332157:Exposure [Clinical Attribute]

Phrase: "of blots"

Phrase: "from single gels where lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1881488:Lysate [Physical Object]

Phrase: "from control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "treated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "loaded"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708715:Loaded [Activity]
   966 E C1550025:Load [Idea or Concept]
   966 E C1704782:Load [Manufactured Object]

Phrase: ";"
Processing 00000000.tx.146: intervening lanes were excised to simplify presentation. 

Phrase: "intervening lanes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "were"

Phrase: "excised"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "simplify"

Phrase: "presentation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449450:Presentation [Idea or Concept]
Processing 00000000.tx.147: WT, wild-type.  

Phrase: "WT, wild-type."
Processing 00000000.tx.148: In differentiated cells, the A53T lines again showed greater susceptibility to accumulating -synuclein after treatment with 3-MA and baf A1. 

Phrase: "In differentiated cells,"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   861   C0007589:Differentiated [Cell Function]
   861   C0007634:Cells [Cell]
   861   C0205615:Differentiated [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789 E C1511938:Differentiation [Clinical Attribute]
   789 E C2945687:Differentiation [Functional Concept]

Phrase: "the A53T lines again"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "greater susceptibility to accumulating -synuclein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0012655:Susceptibility [Clinical Attribute]
   760   C0220898:Susceptibility [Organism Attribute]
   760   C1264642:Susceptibility [Functional Concept]
   760   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "after treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with 3-MA"

Phrase: "and"

Phrase: "baf A1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052919:bafilomycin A1 [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.149: Since the effects of these inhibitors on the wild-type and A30P lines were small, these experiments were repeated to allow us to do statistics. 

Phrase: "Since"

Phrase: "the effects of these inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on the wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "A30P lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "these experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "us to do statistics."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0038215:Statistics [Occupation or Discipline]
   827   C0600673:Statistics [Intellectual Product]
   793 E C2348149:Statistic [Quantitative Concept]
   793 E C2828391:Statistic [Quantitative Concept]
Processing 00000000.tx.150: We compared the densitometry values of -synuclein bands (as a function of tubulin) for 3-MA and baf A1 treatments to those for control cells and calculated the fold increase in -synuclein levels in the cells after drug treatment. 

Phrase: "We"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "the densitometry values of -synuclein bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0175723:Bands [Medical Device]
   771 E C0439645:Band [Spatial Concept]
   771 E C1521913:band [Cell Component]

Phrase: "("

Phrase: "as a function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "of tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: ")"

Phrase: "for 3-MA"

Phrase: "and"

Phrase: "baf A1 treatments to those for control cells"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   744   C0087111:Treatments [Therapeutic or Preventive Procedure]
   711 E C0039798:treatment [Functional Concept]
   711 E C1522326:Treatment [Functional Concept]
   711 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   711 E C1705169:Treatment [Conceptual Entity]
   711 E C3538994:TREATMENT [Research Activity]

Phrase: "and"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "the fold increase in -synuclein levels in the cells"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "after drug treatment."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   861   C0013227:Drug [Pharmacologic Substance]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1254351:Drug [Pharmacologic Substance]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
   805 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   805 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   768 E C0456386:Medicament [Pharmacologic Substance]
Processing 00000000.tx.151: Both inhibitors had significant effects on A30P accumulation (A30P + 3-MA, 1.13-fold increase (0.04 S.E.); p = 0.04 (n = 4 experiments; paired t tests in all cases); A30P + baf A1, 1.19-fold increase ( 0.015 S.E.); p = 0.006 (n = 3)). 

Phrase: "Both inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243077:inhibitors [Chemical Viewed Functionally]
   966 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "had"

Phrase: "significant effects on A30P accumulation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "(A30P + 3-MA,"

Phrase: "1.13-fold increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0442805:Increase [Functional Concept]

Phrase: "(0.04"

Phrase: "S."

Phrase: "E."

Phrase: ")"

Phrase: "; p = 0.04"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "(n = 4 experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "; paired t tests in all cases"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   822   C1709451:Paired t-Test [Intellectual Product]
   753   C0022885:Tests [Laboratory Procedure]
   753   C0392366:Tests [Intellectual Product]
   719 E C0039593:Test [Functional Concept]

Phrase: ")"

Phrase: "; A30P + baf A1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0052919:bafilomycin A1 [Organic Chemical,Pharmacologic Substance]

Phrase: "1.19-fold increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0442805:Increase [Functional Concept]

Phrase: "( 0.015"

Phrase: "S."

Phrase: "E."

Phrase: ")"

Phrase: "; p = 0.006"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "(n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ")."
Processing 00000000.tx.152: While the trend for wild-type -synuclein suggests that these inhibitors were impairing its degradation, the data did not reach significance (wild-type + 3-MA, 1.48-fold increase (0.36 S.E.); p = 0.26 (n = 5); wild-type + baf A1, 1.12-fold increase (0.08 S.E.); p = 0.23 (n = 4)). 

Phrase: "While"

Phrase: "the trend for wild-type -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1521798:trend [Temporal Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "these inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243077:inhibitors [Chemical Viewed Functionally]
   966 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "were"

Phrase: "impairing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221099:impairing [Functional Concept]

Phrase: "its degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "significance"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0237881:Significance [Quantitative Concept]
  1000   C0750502:Significance [Idea or Concept]
   928 E C1546944:Significant [Qualitative Concept]

Phrase: "(wild-type + 3-MA,"

Phrase: "1.48-fold increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0442805:Increase [Functional Concept]

Phrase: "(0.36"

Phrase: "S."

Phrase: "E."

Phrase: ")"

Phrase: "; p = 0.26"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "(n = 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "; wild-type + baf A1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0052919:bafilomycin A1 [Organic Chemical,Pharmacologic Substance]

Phrase: "1.12-fold increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0442805:Increase [Functional Concept]

Phrase: "(0.08"

Phrase: "S."

Phrase: "E."

Phrase: ")"

Phrase: "; p = 0.23"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0795725:P-23 [Organic Chemical,Pharmacologic Substance]
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0450348:23 [Quantitative Concept]
   827   C2603361:P' [Clinical Attribute]

Phrase: "(n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ")."
Processing 00000000.tx.153: When we stimulated autophagy in differentiated cells by adding rapamycin, we saw increased clearance of wild-type, A30P, and A53T -synuclein (Fig. 4B). 

Phrase: "When"

Phrase: "we"

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "autophagy in differentiated cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0004391:Autophagy [Cell Function]

Phrase: "by adding rapamycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0072980:Rapamycin [Antibiotic,Organic Chemical]

Phrase: "we saw increased clearance of wild-type, A30P,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0449297:Clearance [Qualitative Concept]
   744   C1382187:Clearance [Clinical Attribute]
   744   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "A53T -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.154: -Synuclein Is Seen in Vesicles with Autophagic MorphologyWe examined the subcellular localization of -synuclein in our cell lines using immunogold electron microscopy. 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Is"

Phrase: "Seen in Vesicles"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0205397:Seen [Qualitative Concept]
   790   C0333262:VESICLES [Acquired Abnormality]
   756 E C0042789:see [Organism Function]
   756 E C1622418:vesicle [Cell Component]
   756 E C1947903:See [Activity]
   706 E C0205378:Vesicular [Qualitative Concept]

Phrase: "with Autophagic MorphologyWe"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the subcellular localization of -synuclein in our cell lines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "immunogold electron microscopy."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0026019:Electron Microscopy [Laboratory Procedure]
   901   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   827   C0013852:Electron [Quantitative Concept]
   827   C0026018:Microscopy [Laboratory Procedure]
   827   C3463986:Electron [Bird]
   755 E C0013850:Electronic [Manufactured Object]
   755 E C0205288:Microscopic [Qualitative Concept]
   755 E C1547561:Electronic [Idea or Concept]
Processing 00000000.tx.155: We used an antibody to the HA-tag on the -synuclein transgene products to detect -synuclein (Fig. 5). 

Phrase: "We"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an antibody to the HA-tag"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "on the -synuclein transgene products to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1514468:Products [Entity]
   779 E C1704444:Product [Quantitative Concept]

Phrase: "detect -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.156: Gold labeling for -synuclein was apparent over vesicles with autophagic morphology. 

Phrase: "Gold labeling for -synuclein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1167624:Labeling [Mental Process]
   770   C1947902:Labeling [Manufactured Object]
   770   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "was"

Phrase: "apparent over vesicles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0750489:apparent [Idea or Concept]

Phrase: "with autophagic morphology."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0332437:Morphology [Qualitative Concept]
   861   C0543482:morphology [Spatial Concept]
   861   C0700329:Morphology, NOS [Finding]
   861   C0700619:Morphology [Biomedical Occupation or Discipline]
Processing 00000000.tx.157: A degree of caution is required in interpreting these data, since there are no available antibodies to allow specific labeling of mammalian autophagosomes or autolysosomes in general or in PC12 cells. 

Phrase: "A degree of caution"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0441889:Degree [Qualitative Concept]
   770   C0449286:Degree [Quantitative Concept]
   770   C0542560:Degree [Intellectual Product]
   770   C1561545:degree [Quantitative Concept]
   770   C2348088:Degree [Quantitative Concept]

Phrase: "is"

Phrase: "required in interpreting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1285553:interpreting [Functional Concept]
   790   C1514873:Required [Functional Concept]

Phrase: "these data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "since"

Phrase: "there"

Phrase: "are"

Phrase: "no available antibodies to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "specific labeling of mammalian autophagosomes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1167624:Labeling [Mental Process]
   760   C1947902:Labeling [Manufactured Object]
   760   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "or"

Phrase: "autolysosomes in general"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0230822:Autolysosome [Cell Component]

Phrase: "or in PC12 cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0085262:PC12 Cells [Cell]
           PC-12
   770   C0007634:Cells [Cell]
   770   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.158: Nevertheless, the vesicles we observed had morphologies consistent with those described in previous studies of autophagy (30), Huntington's disease (31), and -synuclein (32). 

Phrase: "Nevertheless,"

Phrase: "the vesicles"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333262:VESICLES [Acquired Abnormality]
   966 E C1622418:vesicle [Cell Component]
   916 E C0205378:Vesicular [Qualitative Concept]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "had"

Phrase: "morphologies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0332437:Morphology [Qualitative Concept]
   966   C0543482:morphology [Spatial Concept]
   966   C0700329:Morphology, NOS [Finding]
   966   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "consistent with those"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "described in previous studies of autophagy"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0004391:Autophagy [Cell Function]
   753   C0205156:Previous [Temporal Concept]
   753   C0947630:studies [Laboratory Procedure]
   753   C1552607:previous [Temporal Concept]
   753   C1552738:described [Idea or Concept]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]

Phrase: "(30"

Phrase: ")"

Phrase: ","

Phrase: "Huntington's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0020179:Huntington Disease [Disease or Syndrome]
  1000   C2919056:Huntington's Disease [Functional Concept]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.159: (In these studies, vesicles were identified as autophagic on similar morphologic grounds in the absence of specific antibodies.) 

Phrase: "("

Phrase: "In these studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "vesicles"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333262:VESICLES [Acquired Abnormality]
   966 E C1622418:vesicle [Cell Component]
   916 E C0205378:Vesicular [Qualitative Concept]

Phrase: "were"

Phrase: "identified as autophagic"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]
   718   C0004391:Autophagy [Cell Function]

Phrase: "on similar morphologic grounds"

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of specific antibodies."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")"
Processing 00000000.tx.160: -Synuclein was observed either "free" or associated with electron dense bodies of around 100 nm in diameter. 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "either ""free"""
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332296:free [Functional Concept]
   861   C1880497:Free [Qualitative Concept]
   861   C1996904:Free [Qualitative Concept]

Phrase: "or"

Phrase: "associated with electron dense bodies of"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   773   C1166757:dense body [Cell Component]
   773   C3548425:dense body [Cell Component]
   754   C0596488:electron density [Molecular Sequence]
   753   C0013852:Electron [Quantitative Concept]
   753   C0242821:bodies [Human]
   753   C0439794:Dense [Qualitative Concept]
   753   C1995017:Bodies [Cell Component]
   753   C3463986:Electron [Bird]
   731 E C0178519:body density [Clinical Attribute]
   719 E C0460148:Body [Anatomical Structure]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1268086:Body [Anatomical Structure]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "around 100 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "in diameter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1301886:Diameter [Quantitative Concept]
Processing 00000000.tx.161: There were often two or more gold particles over these bodies, which could indicate -synuclein microaggregates. 

Phrase: "There"

Phrase: "were"

Phrase: "often two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205448:Two [Quantitative Concept]

Phrase: "or"

Phrase: "more gold particles over these bodies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597177:particles [Chemical Viewed Structurally]

Phrase: "which"

Phrase: "could"

Phrase: "indicate -"

Phrase: "synuclein microaggregates."
Processing 00000000.tx.162: Such bodies were also seen in the cytoplasm, sometimes associated with -synuclein. 

Phrase: "Such bodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0242821:bodies [Human]
  1000   C1995017:Bodies [Cell Component]
   966 E C0460148:Body [Anatomical Structure]
   966 E C1268086:Body [Anatomical Structure]

Phrase: "were"

Phrase: "also"

Phrase: "seen in the cytoplasm,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0010834:Cytoplasm [Cell Component]
   770   C0205397:Seen [Qualitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "sometimes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1998882:Sometimes [Temporal Concept]

Phrase: "associated with -synuclein."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.163: It is possible that these electron dense bodies may be dense core granules transporting neurotransmitters. 

Phrase: "It"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "these electron dense bodies"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   884   C1166757:dense body [Cell Component]
   884   C3548425:dense body [Cell Component]
   865   C0596488:electron density [Molecular Sequence]
   827   C0013852:Electron [Quantitative Concept]
   827   C0242821:bodies [Human]
   827   C0439794:Dense [Qualitative Concept]
   827   C1995017:Bodies [Cell Component]
   827   C3463986:Electron [Bird]
   793 E C0460148:Body [Anatomical Structure]
   793 E C1268086:Body [Anatomical Structure]
   755 E C0013850:Electronic [Manufactured Object]
   755 E C0178587:densities [Quantitative Concept]
   755 E C1547561:Electronic [Idea or Concept]

Phrase: "may"

Phrase: "be"

Phrase: "dense core granules"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   988   C0887944:dense core granule [Cell Component]
   896   C1166757:dense granule [Cell Component]
   827   C0010837:Granules [Cell Component]
   827   C0993609:Granules [Biomedical or Dental Material]
   743 E C0205248:Granular [Qualitative Concept]

Phrase: "transporting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005528:Transport, NOS [Cell Function]
   966   C1317949:Transport [Manufactured Object]
   966   C3495449:transport [Medical Device]

Phrase: "neurotransmitters."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027908:Neurotransmitters [Neuroreactive Substance or Biogenic Amine]
Processing 00000000.tx.164: View larger version (154K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(154K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.165: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.166: -Synuclein is seen inside vesicles with autophagic morphology. 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "seen inside vesicles"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0205397:Seen [Qualitative Concept]
   790   C0333262:VESICLES [Acquired Abnormality]
   756 E C0042789:see [Organism Function]
   756 E C1622418:vesicle [Cell Component]
   756 E C1947903:See [Activity]
   706 E C0205378:Vesicular [Qualitative Concept]

Phrase: "with autophagic morphology."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0332437:Morphology [Qualitative Concept]
   861   C0543482:morphology [Spatial Concept]
   861   C0700329:Morphology, NOS [Finding]
   861   C0700619:Morphology [Biomedical Occupation or Discipline]
Processing 00000000.tx.167: Immunogold electron microscopy analysis of -synuclein subcellular localization in our stable, inducible PC12 cell lines. 

Phrase: "Immunogold electron microscopy analysis of -synuclein subcellular localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0475264:Localisation [Functional Concept]
   793   C1744691:localisation [Biologic Function]

Phrase: "in our stable, inducible PC12 cell lines."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   894   C0598091:stable cell line [Cell]
   840   C0007600:Cell lines [Cell]
   840   C0085262:PC12 Cell [Cell]
   804   C0007634:Cell [Cell]
   804   C0205132:lines [Spatial Concept]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   771 E C1550648:Line [Substance]
   771 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.168: Cells were induced to express -synuclein for 48 h and then fixed and processed for electron microscopy. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express -"

Phrase: "synuclein for 48 h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "fixed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231441:Fixed [Finding]
  1000   C0443218:Fixed [Qualitative Concept]
  1000   C2827483:Fixed [Body Substance]

Phrase: "and"

Phrase: "processed for electron microscopy."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0026019:Electron Microscopy [Laboratory Procedure]
   833   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   770   C0013852:Electron [Quantitative Concept]
   770   C0026018:Microscopy [Laboratory Procedure]
   770   C1522240:Processed [Phenomenon or Process]
   770   C3463986:Electron [Bird]
   737 E C1184743:Process [Body Part, Organ, or Organ Component]
Processing 00000000.tx.169: -Synuclein was detected using an anti-HA antibody directed to the epitope tag on the transgene. 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an anti-HA antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "directed to the epitope tag"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0003316:Epitope [Immunologic Factor]
   760   C0037293:Tag [Neoplastic Process]
   760   C0181496:Tag [Manufactured Object]
   760   C1710492:TAG [Gene or Genome]
   726   C0439851:Direct [Qualitative Concept]
   726   C1947931:Direct [Qualitative Concept]

Phrase: "on the transgene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282641:Transgene [Gene or Genome]
Processing 00000000.tx.170: Arrows indicate -synuclein in organelles with autophagic morphology. 

Phrase: "Arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: "indicate -"

Phrase: "synuclein in organelles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with autophagic morphology."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0332437:Morphology [Qualitative Concept]
   861   C0543482:morphology [Spatial Concept]
   861   C0700329:Morphology, NOS [Finding]
   861   C0700619:Morphology [Biomedical Occupation or Discipline]
Processing 00000000.tx.171: Representative images from each form of -synuclein are shown (label at top left-hand corner of photograph). 

Phrase: "Representative images from each form of -synuclein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1704254:Image [Intellectual Product]
   714   C1704922:Image [Entity]
   714   C3542466:Image [Intellectual Product]

Phrase: "are"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "(label at top left-hand corner of photograph"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0181496:Label [Manufactured Object]
   744   C2827499:Label [Governmental or Regulatory Activity]

Phrase: ")."
Processing 00000000.tx.172: The upper wild-type (WT) image shows an example of -synuclein associated with an electron dense vesicle of around 100 nm in diameter, inside the autophagic vesicle.  

Phrase: "The upper wild-type (WT) image"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1704254:Image [Intellectual Product]
   812   C1704922:Image [Entity]
   812   C3542466:Image [Intellectual Product]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "an example of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "associated with an electron dense vesicle of"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0013852:Electron [Quantitative Concept]
   748   C0333262:Vesicle [Acquired Abnormality]
   748   C0439794:Dense [Qualitative Concept]
   748   C1622418:vesicle [Cell Component]
   748   C3463986:Electron [Bird]
   743   C0596488:electron density [Molecular Sequence]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "around 100 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "in diameter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1301886:Diameter [Quantitative Concept]

Phrase: "inside the autophagic vesicle."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0333262:Vesicle [Acquired Abnormality]
   861   C1622418:vesicle [Cell Component]
   789 E C0205378:Vesicular [Qualitative Concept]
Processing 00000000.tx.173: Confocal immunofluorescence studies showed that -synuclein (wild-type, A30P, and A53T) was localized inside acidic vacuoles labeled using LysoTracker Red (Fig. 6). 

Phrase: "Confocal immunofluorescence studies"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0016318:Immunofluorescence [Laboratory Procedure]
   827   C0079603:Immunofluorescence [Laboratory Procedure]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   771 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   755 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(wild-type, A30P,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "and"

Phrase: "A53T"

Phrase: ")"

Phrase: "was"

Phrase: "localized inside acidic vacuoles"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0001128:Acidic [Chemical]
   770   C0042219:Vacuoles [Cell Component]
   770   C0392752:Localized [Spatial Concept]

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "LysoTracker Red"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332575:Red [Finding]
   861   C1260956:Red [Qualitative Concept]
   861   C1531412:LysoTracker [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.174: LysoTracker Red labels acid compartments including degradative autophagic vacuoles and lysosomes. 

Phrase: "LysoTracker Red"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332575:Red [Finding]
   861   C1260956:Red [Qualitative Concept]
   861   C1531412:LysoTracker [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "labels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0181496:Label [Manufactured Object]
  1000   C2827499:Label [Governmental or Regulatory Activity]

Phrase: "acid compartments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1185625:Compartments [Body Space or Junction]
   861   C1382196:Compartments [Natural Phenomenon or Process]
   827 E C2986730:Compartment [Spatial Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "degradative autophagic vacuoles"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0544966:Autophagic vacuoles [Cell Component]
   827   C0042219:Vacuoles [Cell Component]
   755   C0004391:Autophagy [Cell Function]

Phrase: "and"

Phrase: "lysosomes."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0024369:Lysosomes [Cell Component]
   966 E C2984253:Lysosome [Functional Concept]
   916 E C0521450:Lysosomal [Body Location or Region]
Processing 00000000.tx.175: Note that -synuclein was not excluded from these compartments, and speckles of -synuclein immunoreactivity are clearly visible within these vacuoles. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "excluded from these compartments,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C1185625:Compartments [Body Space or Junction]
   770   C1382196:Compartments [Natural Phenomenon or Process]
   770   C1554077:Excluded [Idea or Concept]
   770   C2828389:Excluded [Activity]
   737 E C0332196:Exclude [Functional Concept]
   737 E C2986730:Compartment [Spatial Concept]

Phrase: "and"

Phrase: "speckles of -synuclein immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0597879:immunoreactivity [Molecular Function]

Phrase: "are"

Phrase: "clearly visible within these vacuoles."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205379:Visible [Qualitative Concept]
Processing 00000000.tx.176: These data support our inhibitor/rapamycin studies that implicate a role for the autophagylysosome pathway for -synuclein degradation. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "our inhibitor/rapamycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0072980:Rapamycin [Antibiotic,Organic Chemical]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "that"

Phrase: "implicate"

Phrase: "a role for the autophagylysosome pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "for -synuclein degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]
Processing 00000000.tx.177: View larger version (96K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(96K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.178: 6. 

Phrase: "6."
Processing 00000000.tx.179: -Synuclein is detected inside acidic organelles. 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "detected inside acidic organelles."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0001128:Acidic [Chemical]
   770   C0029219:Organelles [Cell Component]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.180: Cells were induced for 48 h with 2 g/ml doxycycline and then incubated in Earle's balanced salts solution for 2 h at 37 C to induce starvation-mediated autophagy. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "induced for 48 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0205263:Induced [Functional Concept]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "with 2 g/ml doxycycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   756 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated in Earle's balanced salts solution"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   822   C0543134:Balanced salt solution [Inorganic Chemical,Pharmacologic Substance]
   753   C0036140:Salts [Chemical Viewed Structurally]
   753   C0037633:Solution [Substance]
   753   C0205415:Balanced [Functional Concept]
   753   C0525069:Solution [Biomedical or Dental Material]
   753   C1439852:Incubated [Laboratory Procedure]
   719 E C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   719 E C0206136:Salt [Food,Inorganic Chemical]

Phrase: "for 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 37 C to"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "starvation-mediated autophagy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0004391:Autophagy [Cell Function]
Processing 00000000.tx.181: 75 nM LysoTracker Red was added to the Earle's balanced salts solution medium at the start of the 2 h incubation to label acidic organelles. 

Phrase: "75 nM LysoTracker Red"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0332575:Red [Finding]
   812   C1260956:Red [Qualitative Concept]
   812   C1531412:LysoTracker [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "added to the Earle's balanced salts solution medium"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   789   C0543134:Balanced salt solution [Inorganic Chemical,Pharmacologic Substance]
   744   C0009458:Medium [Intellectual Product]
   744   C0036140:Salts [Chemical Viewed Structurally]
   744   C0037633:Solution [Substance]
   744   C0205415:Balanced [Functional Concept]
   744   C0439536:Medium [Quantitative Concept]
   744   C0525069:Solution [Biomedical or Dental Material]
   744   C1524062:Added [Functional Concept]
   744   C1705217:Medium [Substance]
   744   C3244283:medium [Intellectual Product]
   711 E C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   711 E C0206136:Salt [Food,Inorganic Chemical]
   711 E C1883712:Add [Functional Concept]

Phrase: "at the start"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Start [Temporal Concept]

Phrase: "of the 2 h incubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0011744:2 H [Element, Ion, or Isotope]

Phrase: "to label acidic organelles."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0029219:Organelles [Cell Component]
Processing 00000000.tx.182: The cells were then fixed and stained with anti--synuclein antibody. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "fixed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231441:Fixed [Finding]
  1000   C0443218:Fixed [Qualitative Concept]
  1000   C2827483:Fixed [Body Substance]

Phrase: "and"

Phrase: "stained with anti"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "--"

Phrase: "synuclein antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.183: Immunostaining was visualized by confocal microscopy. wt, wild-type.   

Phrase: "Immunostaining"

Phrase: "was"

Phrase: "visualized by confocal microscopy. wt,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0242842:Microscopy, Confocal [Laboratory Procedure]
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0234621:Visualized [Functional Concept]
   760   C2700323:WT [Fish]

Phrase: "wild-type."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.184: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  We have shown that -synuclein is degraded by both the proteasome and autophagy in our inducible PC12 cell lines. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "degraded by both"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "the proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "and"

Phrase: "autophagy in our inducible PC12 cell lines."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0004391:Autophagy [Cell Function]
Processing 00000000.tx.185: Our Western blotting data implicating autophagy as a clearance route for this protein are supported by observations of wild-type, A53T, and A30P species in autophagic vesicles by electron microscopy. 

Phrase: "Our Western blotting data"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
   734   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   717 E C0949466:Western Blot [Laboratory Procedure]

Phrase: "implicating"

Phrase: "autophagy as a clearance route"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0004391:Autophagy [Cell Function]

Phrase: "for this protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "supported by observations of wild-type, A53T,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C1883559:Wild Type [Organism Attribute]
   748   C0302523:observations [Research Activity]
   748   C0332307:Type [Qualitative Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C0700325:observations [Health Care Activity]
   748   C1521721:Supported [Conceptual Entity]
   748   C1547052:*Type [Quantitative Concept]
   748   C3244290:observations [Functional Concept]
   714 E C0183683:Support [Medical Device]
   714 E C1964257:Observation [Diagnostic Procedure]

Phrase: "and"

Phrase: "A30P species in autophagic vesicles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705920:Species [Conceptual Entity]

Phrase: "by electron microscopy."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0026019:Electron Microscopy [Laboratory Procedure]
  1000   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   861   C0013852:Electron [Quantitative Concept]
   861   C0026018:Microscopy [Laboratory Procedure]
   861   C3463986:Electron [Bird]
   789 E C0013850:Electronic [Manufactured Object]
   789 E C0205288:Microscopic [Qualitative Concept]
   789 E C1547561:Electronic [Idea or Concept]
Processing 00000000.tx.186: This is the first report that implicates autophagy as well as the proteasome as a route for -synuclein degradation. 

Phrase: "This"

Phrase: "is"

Phrase: "the first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "implicates"

Phrase: "autophagy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004391:Autophagy [Cell Function]

Phrase: "as well as"

Phrase: "the proteasome as a route"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1325620:proteasome [Cell Component]
   760   C1752727:Proteasome [Molecular Function]

Phrase: "for -synuclein degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]
Processing 00000000.tx.187: Perturbations of autophagy had a more marked effect on the degradation of A53T -synuclein, which may be due to its greater propensity to aggregate, compared with wild-type and A30P (22). 

Phrase: "Perturbations of autophagy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0332453:perturbation [Functional Concept]

Phrase: "had"

Phrase: "a more marked effect on the degradation of A53T -synuclein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "which"

Phrase: "may"

Phrase: "be due to its greater propensity to"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0678226:Due to [Functional Concept]
           due
   748   C0443228:greater [Quantitative Concept]
   748   C1704243:Greater [Quantitative Concept]
   748   C2987476:Be [Conceptual Entity]
   748   C3146286:Due [Idea or Concept]
   714 E C0549177:Great [Quantitative Concept]

Phrase: "aggregate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: ","

Phrase: "compared with wild-type"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1547052:*Type [Quantitative Concept]
   770   C1707455:Compared [Activity]

Phrase: "and"

Phrase: "A30P"

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.188: This would be consistent with the recent report of Verhoef et al. 

Phrase: "This"

Phrase: "would"

Phrase: "be"

Phrase: "consistent with the recent report of Verhoef et al."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.189: (33), suggesting that soluble, but not aggregated, polyglutamine expansions could be degraded by the proteasome. 

Phrase: "(33"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that soluble,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1749467:soluble [Cell Component]
  1000   C1948047:Soluble [Qualitative Concept]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "aggregated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332621:Aggregated [Functional Concept]
   966 E C0205418:Aggregate [Qualitative Concept]

Phrase: ","

Phrase: "polyglutamine expansions"

Phrase: "could"

Phrase: "be"

Phrase: "degraded by the proteasome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1325620:proteasome [Cell Component]
   770   C1752727:Proteasome [Molecular Function]
   770   C1881707:DEGRADED [Phenomenon or Process]
Processing 00000000.tx.190: This is probably because aggregated proteins cannot enter the entrance to the proteasome barrel. 

Phrase: "This"

Phrase: "is"

Phrase: "probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "because"

Phrase: "aggregated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "cannot"

Phrase: "enter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522196:ENTER [Functional Concept]

Phrase: "the entrance to the proteasome barrel."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0337095:Entrance [Spatial Concept]
Processing 00000000.tx.191: If this is the case, then perhaps all aggregated proteins will be preferentially routed to the autophagy-lysosome pathway for degradation. 

Phrase: "If"

Phrase: "this"

Phrase: "is"

Phrase: "the case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "then perhaps"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883708:Then [Temporal Concept]

Phrase: "all aggregated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "will"

Phrase: "be"

Phrase: "preferentially"

Phrase: "routed to the autophagy-lysosome pathway"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0004391:Autophagy [Cell Function]
   753   C0024369:Lysosome [Cell Component]
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]
   753   C2984253:Lysosome [Functional Concept]
   719   C0013153:ROUTE [Functional Concept]
   719   C0449444:Route [Spatial Concept]
   719   C1879941:ROUTE [Intellectual Product]

Phrase: "for degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]
Processing 00000000.tx.192: A model where soluble -synuclein is cleared by the proteasome but aggregated -synuclein is preferentially cleared by autophagy may partially account for the conflicting previous data regarding its metabolism by the proteasome (1519). 

Phrase: "A model where soluble -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "cleared by the proteasome"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0521097:Cleared by [Functional Concept]
           cleared
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1325620:proteasome [Cell Component]
   770   C1752727:Proteasome [Molecular Function]
   737 E C2963144:Clear [Qualitative Concept]

Phrase: "but"

Phrase: "aggregated -"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332621:Aggregated [Functional Concept]
   966 E C0205418:Aggregate [Qualitative Concept]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "preferentially"

Phrase: "cleared by autophagy"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0521097:Cleared by [Functional Concept]
           cleared
   790   C0004391:Autophagy [Cell Function]
   756 E C2963144:Clear [Qualitative Concept]

Phrase: "may"

Phrase: "partially"

Phrase: "account for the conflicting previous data"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0009671:conflicting [Individual Behavior]
   753   C0205156:Previous [Temporal Concept]
   753   C1511726:Data [Idea or Concept]
   753   C1551359:account [Idea or Concept]
   753   C1552607:previous [Temporal Concept]
   753   C2741673:Account # [Clinical Attribute]
   753   C2981730:Account [Classification]
   753   C3245479:data [Medical Device]
   719 E C1705242:Conflict [Qualitative Concept]

Phrase: "regarding"

Phrase: "its metabolism by the proteasome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]

Phrase: "(1519"

Phrase: ")."
Processing 00000000.tx.193: -Synuclein expression and aggregation is likely to vary between different cell types, under different transfection conditions and with different promoters etc., and this may explain the apparent discrepancies (1519). 

Phrase: "-Synuclein expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "vary between different cell types,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0449475:Cell types [Intellectual Product]
   773 E C0007634:Cell Type [Cell]
           Cell
   760   C0332307:Types [Qualitative Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1705242:Different [Qualitative Concept]
   760   C1948049:Cell [Spatial Concept]
   726 E C1547052:*Type [Quantitative Concept]

Phrase: "under different transfection conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "and with different promoters etc.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0086860:promoters [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1515981:And [Idea or Concept]
   760   C1548556:etc. [Idea or Concept]
   760   C1705242:Different [Qualitative Concept]

Phrase: "and"

Phrase: "this"

Phrase: "may"

Phrase: "explain"

Phrase: "the apparent discrepancies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1290905:discrepancies [Finding]

Phrase: "(1519"

Phrase: ")."
Processing 00000000.tx.194: Indeed, recent studies do support a role for the clearance of forms of -synuclein by the proteasome (34, 35). 

Phrase: "Indeed,"

Phrase: "recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "do"

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "a role for the clearance of forms of -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "by the proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "(34,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.195: Our data suggest that the dependence of wild-type and A30P -synuclein on autophagy for degradation is less in cycling versus differentiated cells. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the dependence of wild-type"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0011546:Dependence [Mental Process]
   760   C0439857:Dependence [Mental or Behavioral Dysfunction]
   760   C2698668:DEPENDENCE [Regulation or Law]

Phrase: "and"

Phrase: "A30P -synuclein on autophagy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "for degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "is"

Phrase: "less in cycling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0439092:less [Intellectual Product]
   790   C0547044:Less [Qualitative Concept]
   756   C1511572:Cycle [Temporal Concept]

Phrase: "versus"

Phrase: "differentiated cells."
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   861   C0007589:Differentiated [Cell Function]
   861   C0007634:Cells [Cell]
   861   C0205615:Differentiated [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789 E C1511938:Differentiation [Clinical Attribute]
   789 E C2945687:Differentiation [Functional Concept]
Processing 00000000.tx.196: One could speculate that this may be because the lack of cell division in the differentiated cells may enhance microaggregate formation. 

Phrase: "One"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "could"

Phrase: "speculate"

Phrase: "that"

Phrase: "this"

Phrase: "may"

Phrase: "be"

Phrase: "because"

Phrase: "the lack of cell division"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332268:lack [Qualitative Concept]

Phrase: "in the differentiated cells"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   861   C0007589:Differentiated [Cell Function]
   861   C0007634:Cells [Cell]
   861   C0205615:Differentiated [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789 E C1511938:Differentiation [Clinical Attribute]
   789 E C2945687:Differentiation [Functional Concept]

Phrase: "may"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "microaggregate formation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]
Processing 00000000.tx.197: An interesting feature of our data is that proteasome inhibitors were more efficient than autophagy inhibitors in stabilizing -synuclein. 

Phrase: "An interesting feature of our data"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1521970:Feature [Qualitative Concept]
   753   C1706388:Feature [Conceptual Entity]
   753   C2346469:Feature [Qualitative Concept]
   753   C2348519:Feature [Qualitative Concept]

Phrase: "is"

Phrase: "that proteasome inhibitors"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1443643:Proteasome Inhibitors [Pharmacologic Substance]
  1000   C2266856:Proteasome Inhibitors [Molecular Function]
   966 E C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1325620:proteasome [Cell Component]
   861   C1752727:Proteasome [Molecular Function]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "were"

Phrase: "more efficient than autophagy inhibitors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442799:Efficient [Qualitative Concept]

Phrase: "in stabilizing -synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.198: For instance, in Fig. 

Phrase: "For instance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550608:Instance [Idea or Concept]

Phrase: "in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.199: 4A, bafilomycin A1 has almost no effect, yet rapamycin induces very efficient clearance of -synuclein. 

Phrase: "4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450373:4a [Intellectual Product]
  1000   C1553636:4a [Medical Device]

Phrase: "bafilomycin A1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052919:bafilomycin A1 [Organic Chemical,Pharmacologic Substance]

Phrase: "has"

Phrase: "almost"

Phrase: "no effect,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "yet rapamycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0072980:Rapamycin [Antibiotic,Organic Chemical]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "very efficient clearance of -synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.200: This may be compatible with increased partitioning of the -synuclein pool into an autophagy pathway that may be up-regulated by the overexpression of this protein (32). 

Phrase: "This"

Phrase: "may"

Phrase: "be"

Phrase: "compatible with increased partitioning of the -synuclein pool"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332290:compatible [Idea or Concept]
   744   C1524057:Compatible [Qualitative Concept]

Phrase: "into an autophagy pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "that"

Phrase: "may"

Phrase: "be"

Phrase: "up-regulated by the overexpression of this protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C1514559:Protein Overexpression [Genetic Function]
           Overexpression
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0547043:Up [Spatial Concept]
   744   C0851285:Regulated [Governmental or Regulatory Activity]
   744   C1282911:Up [Spatial Concept]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.201: Neither rapamycin nor autophagy inhibitors, like 3-MA, modulate the clearance of prototypical proteasomal substrates, like transcriptional activators (36) or misfolded intracellular cystic fibrosis transmembrane conductance regulator (37). 

Phrase: "Neither rapamycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072980:Rapamycin [Antibiotic,Organic Chemical]

Phrase: "nor"

Phrase: "autophagy inhibitors,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "like 3-MA,"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the clearance of prototypical proteasomal substrates,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0449297:Clearance [Qualitative Concept]
   753   C1382187:Clearance [Clinical Attribute]
   753   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "like transcriptional activators"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   983   C1336776:Transcriptional Activator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(36"

Phrase: ")"

Phrase: "or"

Phrase: "misfolded intracellular cystic fibrosis transmembrane conductance regulator"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   913   C0056889:Cystic Fibrosis Transmembrane Conductance Regulator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C1413365:CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR [Gene or Genome]
   818   C0010674:Cystic Fibrosis [Disease or Syndrome]
   795   C0016059:Fibrosis [Pathologic Function]
   795   C0182953:REGULATOR [Medical Device]
   795   C0205207:Cystic [Qualitative Concept]
   795   C1167322:transmembrane [Cell Component]
   795   C1704734:Regulator [Medical Device]
   795   C1704735:Regulator [Conceptual Entity]
   795   C2752508:transmembrane [Cell Component]
   724 E C0010709:Cyst [Disease or Syndrome]
   724 E C0334129:Fibrotic [Functional Concept]
   724 E C0686883:Cyst [Eukaryote]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.202: However, alternative explanations for the lower efficacy of autophagy inhibitors compared with proteasome inhibitors on -synuclein clearance may be that the autophagy inhibitors are less effective or that the half-life of total intracellular -synuclein clearance through the proteasome is shorter than through the autophagy route. 

Phrase: "However,"

Phrase: "alternative explanations for the lower efficacy of autophagy inhibitors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0681841:Explanations [Intellectual Product]

Phrase: "compared with proteasome inhibitors on -synuclein clearance"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   778   C1443643:Proteasome Inhibitors [Pharmacologic Substance]
   778   C2266856:Proteasome Inhibitors [Molecular Function]
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0243077:inhibitors [Chemical Viewed Functionally]
   748   C0449297:Clearance [Qualitative Concept]
   748   C1325620:proteasome [Cell Component]
   748   C1382187:Clearance [Clinical Attribute]
   748   C1707455:Compared [Activity]
   748   C1752727:Proteasome [Molecular Function]
   748   C2825073:Clearance [Natural Phenomenon or Process]
   745 E C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   714 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "that"

Phrase: "the autophagy inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "are"

Phrase: "less effective"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280519:effective [Qualitative Concept]
   861   C1704419:Effective [Qualitative Concept]

Phrase: "or"

Phrase: "that"

Phrase: "the half-life of total intracellular -synuclein clearance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0018517:Half-Life [Temporal Concept]
   744   C0376558:Life [Idea or Concept]
   744   C2825407:Half [Quantitative Concept]

Phrase: "through the proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "is"

Phrase: "shorter than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1282927:short [Qualitative Concept]
   799   C1806781:Short [Quantitative Concept]
   799   C2350002:Short [Quantitative Concept]

Phrase: "through the autophagy route."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0013153:ROUTE [Functional Concept]
   861   C0449444:Route [Spatial Concept]
   861   C1879941:ROUTE [Intellectual Product]
Processing 00000000.tx.203: Indeed, this latter possibility would be compatible with the idea that aggregated -synuclein is cleared mainly by autophagy, while soluble forms may be efficiently degraded by the proteasome. 

Phrase: "Indeed,"

Phrase: "this latter possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "would"

Phrase: "be"

Phrase: "compatible with the idea"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:compatible [Idea or Concept]
   770   C1524057:Compatible [Qualitative Concept]

Phrase: "that aggregated -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "cleared"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521097:cleared [Functional Concept]
   966 E C2963144:Clear [Qualitative Concept]

Phrase: "mainly by autophagy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0004391:Autophagy [Cell Function]

Phrase: "while"

Phrase: "soluble forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0348078:forms [Qualitative Concept]
   861   C0376315:Forms [Manufactured Object]
   827 E C1522492:Form [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "efficiently"

Phrase: "degraded by the proteasome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1325620:proteasome [Cell Component]
   770   C1752727:Proteasome [Molecular Function]
   770   C1881707:DEGRADED [Phenomenon or Process]
Processing 00000000.tx.204: We have shown that the autophagy inducer rapamycin increases clearance of all forms of -synuclein. 

Phrase: "We"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the autophagy inducer rapamycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0072980:Rapamycin [Antibiotic,Organic Chemical]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "clearance of all"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0449297:Clearance [Qualitative Concept]
   790   C1382187:Clearance [Clinical Attribute]
   790   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "of -synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.205: This may have therapeutic potential for treatment of Parkinson's disease as rapamycin is intended for long term use in patients. 

Phrase: "This"

Phrase: "may"

Phrase: "have"

Phrase: "therapeutic potential for treatment of Parkinson's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3245505:Potential [Qualitative Concept]

Phrase: "as rapamycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072980:Rapamycin [Antibiotic,Organic Chemical]

Phrase: "is"

Phrase: "intended for long term use"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C0443252:Long-term [Temporal Concept]
   760   C0042153:use [Functional Concept]
   760   C0205166:Long [Qualitative Concept]
   760   C0457083:Use [Functional Concept]
   760   C1283828:Intended [Qualitative Concept]
   760   C1515273:Term [Temporal Concept]
   760   C1551357:intended [Idea or Concept]
   760   C1705313:Term [Idea or Concept]
   760   C1706317:Long [Qualitative Concept]
   760   C1947944:Use [Intellectual Product]
   760   C2826302:TERM [Intellectual Product]

Phrase: "in patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.206: A strategy aimed at down-regulating steady-state levels of -synuclein in humans may be feasible as a means of preventing PD, especially if humans tolerate reductions/absence of this protein as well as mice.  

Phrase: "A strategy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679199:strategy [Mental Process]

Phrase: "aimed at"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C1947946:Aim [Idea or Concept]
   799   C2948600:Aim [Pharmacologic Substance]
   799   C3540471:AIM [Gene or Genome]
   799   C3540472:AIM [Functional Concept]

Phrase: "down-regulating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "steady-state levels of -synuclein in humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "be"

Phrase: "feasible as a means of preventing PD,"

Phrase: "especially"

Phrase: "if"

Phrase: "humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "tolerate"

Phrase: "reductions/absence of this protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "as well as"

Phrase: "mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.207: FOOTNOTES  * This work was supported by the Parkinson's Disease Society (United Kingdom), the Wellcome Trust, and the Association of Commonwealth Universities for funding. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by the Parkinson's Disease Society"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0030567:Parkinson Disease [Disease or Syndrome]
   790   C1521736:Parkinson's Disease [Functional Concept]
   790   C2681933:PARKINSON DISEASE [Gene or Genome]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0037455:society [Organization]
   753   C1521721:Supported [Conceptual Entity]
   719 E C0183683:Support [Medical Device]

Phrase: "(United Kingdom"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041700:United Kingdom [Geographic Area]
   861   C1708611:Kingdom [Classification]
   827   C0166872:unite [Biomedical or Dental Material]

Phrase: ")"

Phrase: ","

Phrase: "the Wellcome Trust,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237935:Trust [Individual Behavior]
   861   C3245466:trust [Idea or Concept]

Phrase: "and"

Phrase: "the Association of Commonwealth Universities"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "for funding."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243098:Funding [Quantitative Concept]
  1000   C0376244:funding [Quantitative Concept]
Processing 00000000.tx.208: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.209: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.210: Section 1734 solely to indicate this fact.  

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.211: Wellcome Trust Senior Fellow in Clinical Science. 

Phrase: "Wellcome Trust Senior Fellow in Clinical Science."
Processing 00000000.tx.212: To whom correspondence should be addressed. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.213: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.214: 44-1223-762608; 

Phrase: "44-1223-762608"

Phrase: ";"
Processing 00000000.tx.215: Fax: 44-1223-331206; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "44-1223-331206"

Phrase: ";"
Processing 00000000.tx.216: E-mail: dcr1000{at}cus.cam.ac.uk . 1 The abbreviations used are: PD, Parkinson's disease; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "dcr1000{at}cus.cam.ac.uk . 1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C0219333:UK 1 [Organic Chemical,Pharmacologic Substance]
   795   C0056599:CuS [Inorganic Chemical]
   795   C1412573:AC [Gene or Genome]
   795   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   795   C3539770:AC [Gene or Genome]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "PD,"

Phrase: "Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: ";"
Processing 00000000.tx.217: HA, hemagglutinin; 

Phrase: "HA,"

Phrase: "hemagglutinin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018909:Haemagglutinin, NOS [Immunologic Factor]

Phrase: ";"
Processing 00000000.tx.218: DAPI, 4',6-diamidino-2-phenylindole; 

Phrase: "DAPI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0057142:DAPI [Organic Chemical,Pharmacologic Substance]

Phrase: "4',"

Phrase: "6-diamidino-2-phenylindole"

Phrase: ";"
Processing 00000000.tx.219: 3-MA, 3-methyladenine; 

Phrase: "3-MA,"

Phrase: "3-methyladenine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0047569:3-methyladenine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ";"
Processing 00000000.tx.220: PIPES, 1,4-piperazinediethanesulfonic acid; 

Phrase: "PIPES,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0071109:PIPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   966 E C1709545:PIPE [Pharmacologic Substance]
   966 E C2828033:Pipe [Manufactured Object]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "4-piperazinediethanesulfonic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.221: baf A1, bafilomycin A1.  

Phrase: "baf A1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052919:bafilomycin A1 [Organic Chemical,Pharmacologic Substance]

Phrase: "bafilomycin A1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052919:bafilomycin A1 [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.222: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Kahle, P. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Kahle,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.223: J., Haass, C., Kretzschmer, H. 

Phrase: "J.,"

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Kretzschmer,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.224: A., and Neumann, M. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Neumann,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.225: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.226: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.227: 82, 449457[CrossRef][Medline] [OrderarticleviaInfotrieve] Spillantini, M. 

Phrase: "82,"

Phrase: "449457"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.228: G., Schmidt, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Schmidt,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.229: L., Lee, V. 

Phrase: "L., Lee,"

Phrase: "V."
Processing 00000000.tx.230: M., Trojanowski, J. 

Phrase: "M."

Phrase: ","

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.231: Q., Jakes, R., and Goedert, M. 

Phrase: "Q., Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.232: (1997) Nature 388, 839840[CrossRef][Medline] [OrderarticleviaInfotrieve] Mezey, E., Dehejia, A. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Nature 388,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "839840"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Mezey,"

Phrase: "E.,"

Phrase: "Dehejia,"

Phrase: "A."
Processing 00000000.tx.233: M., Harta, G., Suchy, S. 

Phrase: "M."

Phrase: ","

Phrase: "Harta,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Suchy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.234: F., Nussbaum, R. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Nussbaum,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.235: L., Brownstein, M. 

Phrase: "L., Brownstein,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.236: J., and Polymeropoulos, M. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Polymeropoulos,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.237: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.238: (1998) Mol. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.239: Psychiatry 3, 493499[CrossRef][Medline] [OrderarticleviaInfotrieve] Polymeropoulos, M. 

Phrase: "Psychiatry 3,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0033872:Psychiatry [Professional or Occupational Group]
   861   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   789 E C0205487:Psychiatric [Functional Concept]

Phrase: "493499"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Polymeropoulos,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.240: H., Lavedan, C., Leroy, E., Ide, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lavedan,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Leroy,"

Phrase: "E.,"

Phrase: "Ide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.241: E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E. 

Phrase: "E.,"

Phrase: "Dehejia,"

Phrase: "A.,"

Phrase: "Dutra,"

Phrase: "A.,"

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Root,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040452:Root [Body Part, Organ, or Organ Component]
  1000   C0242726:Root [Plant]
  1000   C1318154:Root [Body Part, Organ, or Organ Component]
  1000   C1705917:Root [Idea or Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rubenstein,"

Phrase: "J.,"

Phrase: "Boyer,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Stenroos,"

Phrase: "E."
Processing 00000000.tx.242: S., Chandrasekharappa, S., Athanassiadou, A., Papapetropoulos, T., Johnson, W. 

Phrase: "S."

Phrase: ","

Phrase: "Chandrasekharappa,"

Phrase: "S."

Phrase: ","

Phrase: "Athanassiadou,"

Phrase: "A.,"

Phrase: "Papapetropoulos,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Johnson,"

Phrase: "W."
Processing 00000000.tx.243: G., Lazzarini, A. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Lazzarini,"

Phrase: "A."
Processing 00000000.tx.244: M., Duvoisin, R. 

Phrase: "M."

Phrase: ","

Phrase: "Duvoisin,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.245: C., Di Iorio, G., Golbe, L. 

Phrase: "C., Di Iorio,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Golbe,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.246: I., and Nussbaum, R. 

Phrase: "I.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "and"

Phrase: "Nussbaum,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.247: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.248: (1997) Science 276, 20452047[Abstract/Free FullText] Krger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Przuntek, H., Epplen, T. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Science 276,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "20452047"

Phrase: "[Abstract/Free FullText"

Phrase: "] Krger,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kuhn,"

Phrase: "W.,"

Phrase: "Muller,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Woitalla,"

Phrase: "D."

Phrase: ","

Phrase: "Graeber,"

Phrase: "M."

Phrase: ","

Phrase: "Kosel,"

Phrase: "S."

Phrase: ","

Phrase: "Przuntek,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Epplen,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.249: T., Schols, L., and Riess, O. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Schols,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Riess,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.250: (1998) Nat. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.251: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.252: 18, 106108[Medline] [OrderarticleviaInfotrieve] Feany, M. 

Phrase: "18,"

Phrase: "106108"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Feany,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.253: B., and Bender, W. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Bender,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0491941:BENDER [Medical Device]

Phrase: "W."
Processing 00000000.tx.254: W. 

Phrase: "W."
Processing 00000000.tx.255: (2000) Nature 404, 394398[CrossRef][Medline] [OrderarticleviaInfotrieve] Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., and Mucke, L. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Nature 404,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "394398"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Masliah,"

Phrase: "E.,"

Phrase: "Rockenstein,"

Phrase: "E.,"

Phrase: "Veinbergs,"

Phrase: "I.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "Mallory,"

Phrase: "M."

Phrase: ","

Phrase: "Hashimoto,"

Phrase: "M."

Phrase: ","

Phrase: "Takeda,"

Phrase: "A.,"

Phrase: "Sagara,"

Phrase: "Y.,"

Phrase: "Sisk,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Mucke,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.256: (2000) Science 287, 12651269[Abstract/Free FullText] Abeliovich, A., Schmitz, Y., Farinas, I., Choi-Lundberg, D., Ho, W. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Science 287,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "12651269"

Phrase: "[Abstract/Free FullText"

Phrase: "] Abeliovich,"

Phrase: "A.,"

Phrase: "Schmitz,"

Phrase: "Y.,"

Phrase: "Farinas,"

Phrase: "I.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "Choi-Lundberg,"

Phrase: "D."

Phrase: ","

Phrase: "Ho,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1832110:HO [Gene or Genome]

Phrase: "W."
Processing 00000000.tx.257: H., Castillo, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Castillo,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.258: E., Shinsky, N., Verdugo, J. 

Phrase: "E.,"

Phrase: "Shinsky,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Verdugo,"

Phrase: "J."
Processing 00000000.tx.259: M., Armanini, M., Ryan, A., Hynes, M., Phillips, H., Sulzer, D., and Rosenthal, A. 

Phrase: "M."

Phrase: ","

Phrase: "Armanini,"

Phrase: "M."

Phrase: ","

Phrase: "Ryan,"

Phrase: "A.,"

Phrase: "Hynes,"

Phrase: "M."

Phrase: ","

Phrase: "Phillips,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sulzer,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Rosenthal,"

Phrase: "A."
Processing 00000000.tx.260: (2000) Neuron 25, 239252[Medline] [OrderarticleviaInfotrieve] Chen, P. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Neuron 25,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "239252"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.261: E., Specht, C. 

Phrase: "E.,"

Phrase: "Specht,"

Phrase: "C."
Processing 00000000.tx.262: G., Morris, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Morris,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.263: G., and Schoepfer, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Schoepfer,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.264: (2002) Eur. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.265: J. 

Phrase: "J."
Processing 00000000.tx.266: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.267: 16, 154158[CrossRef][Medline] [OrderarticleviaInfotrieve] Cabin, D. 

Phrase: "16,"

Phrase: "154158"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Cabin,"

Phrase: "D."
Processing 00000000.tx.268: E., Shimazu, K., Murphy, D., Cole, N. 

Phrase: "E.,"

Phrase: "Shimazu,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Murphy,"

Phrase: "D."

Phrase: ","

Phrase: "Cole,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.269: B., Gottschalk, W., McIlwain, K. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Gottschalk,"

Phrase: "W.,"

Phrase: "McIlwain,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.270: L., Orrison, B., Chen, A., Ellis, C. 

Phrase: "L., Orrison,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "A.,"

Phrase: "Ellis,"

Phrase: "C."
Processing 00000000.tx.271: E., Paylor, R., Lu, B., and Nussbaum, R. 

Phrase: "E.,"

Phrase: "Paylor,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024171:LU [Body System]
  1000   C0024176:LU [Geographic Area]
  1000   C2697939:LU [Quantitative Concept]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Nussbaum,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.272: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.273: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.274: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.275: 22, 87978807[Abstract/Free FullText] Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., and Shimizu, N. 

Phrase: "22,"

Phrase: "87978807"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kitada,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Asakawa,"

Phrase: "S."

Phrase: ","

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Matsumine,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yamamura,"

Phrase: "Y.,"

Phrase: "Minoshima,"

Phrase: "S."

Phrase: ","

Phrase: "Yokochi,"

Phrase: "M."

Phrase: ","

Phrase: "Mizuno,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Shimizu,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.276: (1998) Nature 392, 605608[CrossRef][Medline] [OrderarticleviaInfotrieve] Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nature 392,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "605608"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Leroy,"

Phrase: "E.,"

Phrase: "Boyer,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Auburger,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Leube,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Ulm,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Mezey,"

Phrase: "E.,"

Phrase: "Harta,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Brownstein,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.277: J., Jonnalagada, S., Chernova, T., Dehejia, A., Lavedon, C., Gasser, T., Steinbach, P. 

Phrase: "J.,"

Phrase: "Jonnalagada,"

Phrase: "S."

Phrase: ","

Phrase: "Chernova,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Dehejia,"

Phrase: "A.,"

Phrase: "Lavedon,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Gasser,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Steinbach,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.278: J., Wilkinson, K. 

Phrase: "J.,"

Phrase: "Wilkinson,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.279: D., and Polymeropoulos, M. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Polymeropoulos,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.280: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.281: (1998) Nature 395, 451452[CrossRef][Medline] [OrderarticleviaInfotrieve] Ciechanover, A. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nature 395,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "451452"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ciechanover,"

Phrase: "A."
Processing 00000000.tx.282: (1998) EMBO J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.283: 17, 71517160[Free FullText] Ii, K., Ito, H., Tanaka, K., and Hirano, A. 

Phrase: "17,"

Phrase: "71517160"

Phrase: "[Free FullText"

Phrase: "] Ii,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ito,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415618:ITO [Gene or Genome]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tanaka,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Hirano,"

Phrase: "A."
Processing 00000000.tx.284: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.285: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.286: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.287: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.288: 56, 125131[Medline] [OrderarticleviaInfotrieve] Bennett, M. 

Phrase: "56,"

Phrase: "125131"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bennett,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.289: C., Bishop, J. 

Phrase: "C., Bishop,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1551458:Bishop [Population Group]

Phrase: "J."
Processing 00000000.tx.290: F., Leng, Y., Chock, P. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Leng,"

Phrase: "Y.,"

Phrase: "Chock,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.291: B., Chase, T. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Chase,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.292: N., and Mouradian, M. 

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Mouradian,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.293: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.294: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.295: Biol. 

Phrase: "Biol."
Processing 00000000.tx.296: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.297: 274, 3385533858[Abstract/Free FullText] McNaught, K. 

Phrase: "274,"

Phrase: "3385533858"

Phrase: "[Abstract/Free FullText"

Phrase: "] McNaught,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.298: St. 

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.299: P., Mytilineou, C., JnoBaptiste, R., Yabut, J., Shashidharan, P., Jenner, P., and Olanow, C. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Mytilineou,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "JnoBaptiste,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Yabut,"

Phrase: "J.,"

Phrase: "Shashidharan,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Jenner,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Olanow,"

Phrase: "C."
Processing 00000000.tx.300: W. 

Phrase: "W."
Processing 00000000.tx.301: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.302: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.303: 81, 301306[CrossRef][Medline] [OrderarticleviaInfotrieve] Tofaris, G. 

Phrase: "81,"

Phrase: "301306"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Tofaris,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.304: K., Layfield, R., and Spillantini, M. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Layfield,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.305: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.306: (2001) FEBS Lett. 

Phrase: "(2001"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.307: 509, 2226[CrossRef][Medline] [OrderarticleviaInfotrieve] Rideout, H. 

Phrase: "509,"

Phrase: "2226"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Rideout,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.308: J., Larsen, K. 

Phrase: "J.,"

Phrase: "Larsen,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.309: E., Sulzer, D., and Stefanis, L. 

Phrase: "E.,"

Phrase: "Sulzer,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Stefanis,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.310: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.311: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.312: 78, 899908[CrossRef][Medline] [OrderarticleviaInfotrieve] Ancolio, K., Alves da Costa, C., Ueda, K., and Checler, F. 

Phrase: "78,"

Phrase: "899908"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ancolio,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Alves da Costa,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0035561:Costa [Body Part, Organ, or Organ Component]
   734 E C1281577:Rib [Body Part, Organ, or Organ Component]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Ueda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Checler,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.313: (2000) Neurosci. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.314: Lett. 

Phrase: "Lett."
Processing 00000000.tx.315: 285, 7982[CrossRef][Medline] [OrderarticleviaInfotrieve] Klionsky, D. 

Phrase: "285,"

Phrase: "7982"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Klionsky,"

Phrase: "D."
Processing 00000000.tx.316: J., and Oshumi, Y. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Oshumi,"

Phrase: "Y."
Processing 00000000.tx.317: (1999) Annu. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.318: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.319: Cell Dev. 

Phrase: "Cell Dev."
Processing 00000000.tx.320: Biol. 

Phrase: "Biol."
Processing 00000000.tx.321: 15, 132[CrossRef][Medline] [OrderarticleviaInfotrieve] Ravikumar, B., Duden, R., and Rubinsztein, D. 

Phrase: "15,"

Phrase: "132"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ravikumar,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Duden,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Rubinsztein,"

Phrase: "D."
Processing 00000000.tx.322: C. 

Phrase: "C."
Processing 00000000.tx.323: (2002) Hum. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Hum."
Processing 00000000.tx.324: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.325: Gen. 

Phrase: "Gen."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704351:GEN [Quantitative Concept]
  1000   C2239486:Gen [Gene or Genome]
Processing 00000000.tx.326: 11, 11071117[Abstract/Free FullText] Conway, K. 

Phrase: "11,"

Phrase: "11071117"

Phrase: "[Abstract/Free FullText"

Phrase: "] Conway,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.327: A., Harper, J. 

Phrase: "A.,"

Phrase: "Harper,"

Phrase: "J."
Processing 00000000.tx.328: D., and Lansbury, P. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.329: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.330: (1998) Nat. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.331: Med. 

Phrase: "Med."
Processing 00000000.tx.332: 4, 13181320[CrossRef][Medline] [OrderarticleviaInfotrieve] Greene, L. 

Phrase: "4,"

Phrase: "13181320"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Greene,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.333: A., and Tischler, A. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Tischler,"

Phrase: "A."
Processing 00000000.tx.334: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.335: (1976) Proc. 

Phrase: "(1976"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.336: Natl. 

Phrase: "Natl."
Processing 00000000.tx.337: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.338: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.339: U. 

Phrase: "U."
Processing 00000000.tx.340: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.341: A. 

Phrase: "A."
Processing 00000000.tx.342: 73, 24242428[Abstract] Furlong, R. 

Phrase: "73,"

Phrase: "24242428"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Furlong,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552921:Furlong [Quantitative Concept]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.343: A., Narain, Y., Rankin, J., Wyttenbach, A., and Rubinsztein, D. 

Phrase: "A.,"

Phrase: "Narain,"

Phrase: "Y.,"

Phrase: "Rankin,"

Phrase: "J.,"

Phrase: "Wyttenbach,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Rubinsztein,"

Phrase: "D."
Processing 00000000.tx.344: C. 

Phrase: "C."
Processing 00000000.tx.345: (2000) Biochem. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.346: J. 

Phrase: "J."
Processing 00000000.tx.347: 346, 577581[CrossRef][Medline] [OrderarticleviaInfotrieve] Skepper, J. 

Phrase: "346,"

Phrase: "577581"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Skepper,"

Phrase: "J."
Processing 00000000.tx.348: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.349: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.350: Microscopy 199, 136[CrossRef][Medline] [OrderarticleviaInfotrieve] Narain, Y., Wyttenbach, A., Rankin, J., Furlong, R. 

Phrase: "Microscopy 199,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026018:Microscopy [Laboratory Procedure]
   789 E C0205288:Microscopic [Qualitative Concept]

Phrase: "136"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Narain,"

Phrase: "Y.,"

Phrase: "Wyttenbach,"

Phrase: "A.,"

Phrase: "Rankin,"

Phrase: "J.,"

Phrase: "Furlong,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552921:Furlong [Quantitative Concept]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.351: A., and Rubinsztein, D. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Rubinsztein,"

Phrase: "D."
Processing 00000000.tx.352: C. 

Phrase: "C."
Processing 00000000.tx.353: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.354: Med. 

Phrase: "Med."
Processing 00000000.tx.355: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.356: 36, 739746[Abstract/Free FullText] Ostrowska, H., Wojcik, C., Wilk, S., Omura, S., Kozlowski, L., Stoklosa, T., Worowski, K., and Radziwon, P. 

Phrase: "36,"

Phrase: "739746"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ostrowska,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wojcik,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Wilk,"

Phrase: "S."

Phrase: ","

Phrase: "Omura,"

Phrase: "S."

Phrase: ","

Phrase: "Kozlowski,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Stoklosa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Worowski,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Radziwon,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.357: (2000) Int. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.358: J. 

Phrase: "J."
Processing 00000000.tx.359: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.360: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.361: 32, 747757[CrossRef][Medline] [OrderarticleviaInfotrieve] Biederbick, A., Kern, H. 

Phrase: "32,"

Phrase: "747757"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Biederbick,"

Phrase: "A.,"

Phrase: "Kern,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.362: F., and Elsasser, H. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Elsasser,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.363: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.364: (1995) Eur. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.365: J. 

Phrase: "J."
Processing 00000000.tx.366: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.367: 66, 314[Medline] [OrderarticleviaInfotrieve] Yamamoto, A., Tagawa, Y., Yoshimori, T., Moriyama, Y., Masaki, R., and Tashiro, Y. 

Phrase: "66,"

Phrase: "314"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "A.,"

Phrase: "Tagawa,"

Phrase: "Y.,"

Phrase: "Yoshimori,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Moriyama,"

Phrase: "Y.,"

Phrase: "Masaki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1461631:masaki [Plant]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Tashiro,"

Phrase: "Y."
Processing 00000000.tx.368: (1998) Cell Struct. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Cell Struct."
Processing 00000000.tx.369: Funct. 

Phrase: "Funct."
Processing 00000000.tx.370: 23, 3342[Medline] [OrderarticleviaInfotrieve] Mizushima, N., Yamamoto, A., Hatano, M., Kobayashi, Y., Kabeya, Y., Suzuki, K., Tokuhisa, T., Ohsumi, Y., and Yoshimori, T. 

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "3342"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Mizushima,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "A.,"

Phrase: "Hatano,"

Phrase: "M."

Phrase: ","

Phrase: "Kobayashi,"

Phrase: "Y.,"

Phrase: "Kabeya,"

Phrase: "Y.,"

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tokuhisa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ohsumi,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Yoshimori,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.371: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.372: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.373: 152, 657667[Abstract/Free FullText] Kegel, K. 

Phrase: "152,"

Phrase: "657667"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kegel,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.374: B., Kim, M., Sapp, E., McIntyre, C., Castao, J. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Kim,"

Phrase: "M."

Phrase: ","

Phrase: "Sapp,"

Phrase: "E.,"

Phrase: "McIntyre,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Castao,"

Phrase: "J."
Processing 00000000.tx.375: G., Aronin, N., and DiFiglia, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Aronin,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "DiFiglia,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.376: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.377: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.378: 20, 72687278[Abstract/Free FullText] Stefanis, L., Larsen, K. 

Phrase: "20,"

Phrase: "72687278"

Phrase: "[Abstract/Free FullText"

Phrase: "] Stefanis,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Larsen,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.379: E., Rideout, H. 

Phrase: "E.,"

Phrase: "Rideout,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.380: J., Sulzer, D., and Greene, L. 

Phrase: "J.,"

Phrase: "Sulzer,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Greene,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.381: A. 

Phrase: "A."
Processing 00000000.tx.382: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.383: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.384: 21, 95499560[Abstract/Free FullText] Verhoef, L. 

Phrase: "21,"

Phrase: "95499560"

Phrase: "[Abstract/Free FullText"

Phrase: "] Verhoef,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.385: G., Lindsten, K., Masucci, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Lindsten,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Masucci,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.386: G., and Dantuma, N. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Dantuma,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.387: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.388: (2002) Hum. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Hum."
Processing 00000000.tx.389: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.390: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.391: 11, 26892700[Abstract/Free FullText] Shimura, H., Schlossmacher, M. 

Phrase: "11,"

Phrase: "26892700"

Phrase: "[Abstract/Free FullText"

Phrase: "] Shimura,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Schlossmacher,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.392: G., Hattori, N., Frosch, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Frosch,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.393: P., Trockenbacher, A., Schneider, R., Mizuno, Y., Kosik, K. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Trockenbacher,"

Phrase: "A.,"

Phrase: "Schneider,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Mizuno,"

Phrase: "Y.,"

Phrase: "Kosik,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.394: S., and Selkoe, D. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.395: J. 

Phrase: "J."
Processing 00000000.tx.396: (2001) Science 293, 263269[Abstract/Free FullText] Petrucelli, L., O'Farrell, C., Lockhart, P. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Science 293,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "263269"

Phrase: "[Abstract/Free FullText"

Phrase: "] Petrucelli,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "O'Farrell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lockhart,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.397: J., Baptista, M., Kehoe, K., Vink, L., Choi, P., Wolozin, B., Farrer, M., Hardy, J., and Cookson, M. 

Phrase: "J.,"

Phrase: "Baptista,"

Phrase: "M."

Phrase: ","

Phrase: "Kehoe,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Vink,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Choi,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wolozin,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Cookson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.398: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.399: (2002) Neuron 36, 10071019[Medline] [OrderarticleviaInfotrieve] Molinari, E., Gilman, M., and Natesan, S. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Neuron 36,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "10071019"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Molinari,"

Phrase: "E.,"

Phrase: "Gilman,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Natesan,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.400: (1999) EMBO J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.401: 18, 64396447[Abstract/Free FullText] Gelman, M. 

Phrase: "18,"

Phrase: "64396447"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gelman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.402: S., Kannegaard, E. 

Phrase: "S."

Phrase: ","

Phrase: "Kannegaard,"

Phrase: "E."
Processing 00000000.tx.403: S., and Kopito, R. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Kopito,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.404: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.405: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.406: Biol. 

Phrase: "Biol."
Processing 00000000.tx.407: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.408: 277, 1170911714[Abstract/Free FullText]

Phrase: "277,"

Phrase: "1170911714"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

